ExamWorks Group, Inc. - FORM 10-Q

Attached files

file	filename
EX-31.1 - EXHIBIT 31.1 - ExamWorks Group, Inc.	ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - ExamWorks Group, Inc.	ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - ExamWorks Group, Inc.	ex32-1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

	(Mark One)

☒	Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended September 30, 2015.

☐	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Commission File Number: 001-34930

EXAMWORKS GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware

27-2909425

(State or other jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

3280 PEACHTREE ROAD, N.E., SUITE 2625

ATLANTA, GEORGIA 30305

(Address of principal executive offices)

Telephone Number (404) 952-2400

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes☒ No☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes☒ No☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes☐ No☒

As of November 1, 2015, ExamWorks Group, Inc. had 41,960,000 shares of Common Stock outstanding.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

September 30, 2015

FORM 10-Q QUARTERLY REPORT

TABLE OF CONTENTS

		Page

PART I – Financial Information

Item 1.	Financial Statements	3

	Consolidated Balance Sheets as of December 31, 2014 and September 30, 2015 (Unaudited)	3

	Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2014 and 2015 (Unaudited)	4

	Consolidated Statements of Cash Flows for the nine months ended September 30, 2014 and 2015 (Unaudited)	5

	Notes to Consolidated Financial Statements (Unaudited)	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	32

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	45

Item 4.	Controls and Procedures	46

PART II – Other Information

Item 1.	Legal Proceedings	46

Item 1A.	Risk Factors	46

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	46

Item 3.	Defaults Upon Senior Securities	46

Item 4.	Mine Safety Disclosures	46

Item 5.	Other Information	47

Item 6.	Exhibits	47

Signatures		49

PART 1. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

	December 31,			September 30,
	2014			2015
Assets
Current assets:
Cash and cash equivalents	$	9,751		$	127,338
Accounts receivable, net		203,189			225,509
Prepaid expenses		13,805			14,900
Deferred tax assets		3,776			5,072
Other current assets		1,437			3,488
Total current assets		231,958			376,307
Property, equipment and leasehold improvements, net		15,726			17,078
Goodwill		495,679			489,532
Intangible assets, net		102,583			71,496
Long-term accounts receivable, less current portion		46,401			52,497
Deferred tax assets, noncurrent		29,682			49,658
Deferred financing costs, net		6,169			9,753
Other assets		1,946			2,100
Total assets	$	930,144		$	1,068,421
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	57,033		$	59,240
Accrued expenses		53,978			54,274
Accrued interest expense		10,667			12,892
Deferred revenue		6,402			4,158
Current portion of contingent earnout obligation		4,473			—
Current portion of working capital facilities		40,396			—
Other current liabilities		6,950			5,841
Total current liabilities		179,899			136,405
Senior unsecured notes payable		250,000			500,000
Senior secured revolving credit facility and working capital facilities, less current portion		143,853			38,838
Long-term contingent earnout obligation, less current portion		2,114			—
Deferred tax liability, noncurrent		—			5,587
Other long-term liabilities		9,403			12,727
Total liabilities		585,269			693,557
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; Authorized 50,000 shares; no shares issued and outstanding at December 31, 2014 and September 30, 2015		—			—
Common stock, $0.0001 par value; Authorized 250,000 shares; issued and outstanding 40,371 and 41,945 shares at December 31, 2014 and September 30, 2015, respectively		4			4
Additional paid-in capital		403,945			441,288
Accumulated other comprehensive loss		(14,376	)		(23,046	)
Accumulated deficit		(36,210	)		(34,894	)
Treasury stock, at cost; Outstanding 905 shares at December 31, 2014 and September 30, 2015		(8,488	)		(8,488	)
Total stockholders’ equity		344,875			374,864
Total liabilities and stockholders' equity	$	930,144		$	1,068,421

The accompanying notes are an integral part of these consolidated financial statements.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)

(In thousands, except per share amounts)

(Unaudited)

	For the three months ended September 30,						For the nine months ended September 30,
	2014			2015			2014			2015

Revenues	$	204,078		$	206,033		$	573,551		$	611,087
Costs and expenses:
Costs of revenues		130,597			134,446			366,483			399,047
Selling, general and administrative expenses		43,534			40,455			126,652			125,328
Depreciation and amortization		15,705			12,997			44,905			41,574
Total costs and expenses		189,836			187,898			538,040			565,949
Income from operations		14,242			18,135			35,511			45,138
Interest and other expenses, net:
Interest expense, net		8,361			8,000			23,842			25,952
Loss on early extinguishment of debt		—			—			—			18,619
Other expense, net		(6	)		—			185			—
Total interest and other expenses, net		8,355			8,000			24,027			44,571
Income before income taxes		5,887			10,135			11,484			567
Provision (benefit) for income taxes		2,472			2,980			4,826			(749	)
Net income	$	3,415		$	7,155		$	6,658		$	1,316

Comprehensive Income (Loss):
Net income	$	3,415		$	7,155		$	6,658		$	1,316
Foreign currency translation adjustments, net of tax		(4,956	)		(4,607	)		(3,985	)		(8,670	)
Total comprehensive income (loss)	$	(1,541	)	$	2,548		$	2,673		$	(7,354	)

Per share data:
Net income per share:
Basic	$	0.09		$	0.17		$	0.17		$	0.03
Diluted	$	0.08		$	0.17		$	0.16		$	0.03

Weighted average number of common shares outstanding:
Basic		39,251			41,384			38,259			40,936
Diluted		41,647			43,158			40,897			42,981

The accompanying notes are an integral part of these consolidated financial statements.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	For the nine months ended September 30,
	2014			2015
Operating activities:
Net income	$	6,658		$	1,316
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		44,905			41,574
Amortization of deferred rent		(153	)		350
Share-based compensation		14,660			18,094
Excess tax benefit related to share-based compensation		(12,700	)		(3,111	)
Provision for doubtful accounts		4,833			5,505
Amortization of deferred financing costs		1,735			1,411
Deferred income taxes		(9,806	)		(7,757	)
Loss on early extinguishment of debt		—			18,619
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable		(37,512	)		(39,559	)
Prepaid expenses and other current assets		(4,121	)		(954	)
Accounts payable and accrued expenses		22,137			6,875
Accrued interest expense		(5,356	)		2,225
Deferred revenue and customer deposits		(48	)		(1,458	)
Other liabilities		(271	)		(1,502	)
Net cash provided by operating activities		24,961			41,628
Investing activities:
Cash paid for acquisitions, net		(187,402	)		(11,770	)
Purchases of building, equipment and leasehold improvements, net		(6,192	)		(7,337	)
Working capital and other settlements for acquisitions		(2,366	)		(181	)
Proceeds from (cash paid for) foreign currency net investment hedges		(362	)		4,122
Other		(939	)		(1,427	)
Net cash used in investing activities		(197,261	)		(16,593	)
Financing activities:
Borrowings under senior unsecured notes		—			500,000
Borrowings under senior secured revolving credit facility		269,621			25,478
Proceeds from the exercise of options and warrants		35,394			13,737
Excess tax benefit related to share-based compensation		12,700			3,111
Repayment of subordinated unsecured notes payable		(333	)		—
Net borrowings (repayments) under working capital facilities		7,506			(607	)
Repayment of contingent earnout obligation		(4,362	)		(5,064	)
Payment of deferred financing costs		(251	)		(8,706	)
Payment for early redemption of senior unsecured notes		—			(14,618	)
Repayments under senior secured revolving credit facility		(151,290	)		(169,331	)
Repayment of senior unsecured notes		—			(250,000	)
Other		(53	)		—
Net cash provided by financing activities		168,932			94,000
Exchange rate impact on cash and cash equivalents		(350	)		(1,448	)
Net increase (decrease) in cash and cash equivalents		(3,718	)		117,587
Cash and cash equivalents, beginning of period		12,829			9,751
Cash and cash equivalents, end of period	$	9,111		$	127,338

Supplemental disclosures of cash flow information:
Cash paid for interest	$	27,019		$	22,137
Cash paid for income taxes		1,536			7,648

The accompanying notes are an integral part of these consolidated financial statements.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(1)

Nature of Operations and Basis of Presentation

ExamWorks Group, Inc. (“ExamWorks” or the “Company”) is a leading provider of independent medical examinations (“IMEs”), peer and bill reviews, Medicare compliance services, case management services and other related services (“IME services” or the “IME industry”). ExamWorks, Inc. was incorporated as a Delaware corporation on April 27, 2007. Since 2008 through the date of this filing, ExamWorks completed 53 acquisitions. As of September 30, 2015, ExamWorks, Inc. operated out of 66 service centers serving all 50 U.S. states, Canada, the United Kingdom and Australia.

The consolidated financial statements of the Company as of September 30, 2015 and for the periods ended September 30, 2014 and 2015 included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and have not been audited by its independent registered public accounting firm. In the opinion of management, all adjustments of a normal and recurring nature necessary to present fairly the financial position and results of operations and cash flows for all periods presented have been made. Pursuant to SEC rules and regulations, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted from these statements unless significant changes have taken place since the end of the Company's most recent fiscal year. The Company's December 31, 2014 Consolidated Balance Sheet was derived from audited consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, (the “Form 10-K”), but does not include all disclosures required by U.S. GAAP. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Form 10-K. The results of operations for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.

The consolidated financial statements include the accounts of ExamWorks and its 100% owned subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.

(2)

Summary of Significant Accounting Policies

(a)

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which they believe are reasonable in the circumstances and actual results could differ from those estimates. The more significant estimates reflected in these consolidated financial statements include the valuation of equity awards, purchase price allocations, useful lives of intangible assets, potential impairment of goodwill and intangible assets, the allowance for doubtful accounts, the portion of accounts receivable deemed to be long term in nature, and the valuation of deferred tax assets, share-based compensation and derivative instruments.

(b)

Foreign Currencies

Assets and liabilities recorded in foreign currencies are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates of exchange prevailing during the year. Translation adjustments resulting from this process are recorded to other comprehensive income (loss) and are reported net of the effect of income taxes on the consolidated financial statements (See Note 2 (p) to the Consolidated Financial Statements).

(c)

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2014 and September 30, 2015.

(d)

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable consist of amounts owed to the Company for services provided in the normal course of business and are reported net of allowance for doubtful accounts, which amounted to $9.9 million and $11.7 million as of December 31, 2014 and September 30, 2015, respectively. Generally, no collateral is received from customers and additions to the allowance are based on ongoing credit evaluations of customers with general credit experience being within the range of management’s expectations. Accounts are reviewed regularly for collectability and those deemed uncollectible are written off. The Company assumes, that on average, all accounts receivable will be collected within one year and thus classifies these as current assets; however there are certain receivables, primarily in the U.K., that have aged longer than one year as of December 31, 2014 and September 30, 2015, and the Company has recorded an estimate for those receivables that will not be collected within one year as long-term in the Consolidated Balance Sheets.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(e)

Concentrations of Credit Risk

The Company routinely assesses the financial strength of its customers and establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. For the three and nine months ended September 30, 2014 and 2015, no individual customer accounted for more than 10% of revenues. At December 31, 2014 and September 30, 2015 there was one individual customer that accounted for approximately 14% and 16%, respectively, of the accounts receivable balance.

As of September 30, 2015, the Company had cash and cash equivalents totaling approximately $127.3 million. These amounts were held for future acquisition and working capital purposes and were held in non-interest bearing accounts, of which $115.2 million were held in deposit accounts in the U.S. with only standard FDIC insurance coverage for deposit accounts up to $250,000, per depositor and account ownership category.

(f)

Property, Equipment and Leasehold Improvements

Property, equipment and leasehold improvements are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets and accelerated methods for income tax purposes. Leasehold improvements are amortized over the lesser of their expected useful life or the remaining lease term. Maintenance and repair costs are expensed as incurred.

(g)

Long-Lived Assets

In accordance with Impairment or Disposal of Long-Lived Assets, Subsections of Financial Accounting Standards Board (“FASB”) ASC Subtopic 360-10 (“ASC 360”), Property, Plant, and Equipment — Overall, long-lived assets, such as equipment and purchased intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models (using market participant assumptions), quoted market values and third-party independent appraisals, as considered necessary. At December 31, 2014 and September 30, 2015, no impairment was noted.

(h)

Goodwill and Other Intangible Assets

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at least annually in accordance with the provisions of FASB ASC Topic 350, Intangibles — Goodwill and Other (“ASC 350”). The goodwill impairment test is a two-step test. Under the first step, the fair values of the reporting units are compared with their carrying values (including goodwill). If the fair value of a reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis (using market participant assumptions). If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed.

The Company performed its annual impairment review of goodwill in October of 2014 and it was determined that the carrying amount of goodwill was not impaired as the fair value of the reporting units substantially exceeded their carrying values and there have been no subsequent developments that would indicate impairment exists as of September 30, 2015. The goodwill impairment review will continue to be performed annually and more frequently if facts and circumstances warrant a review.

ASC 350 also requires that intangible assets with definite lives be amortized over their estimated useful lives. Currently, customer relationships, trade names, covenants not-to-compete and technology are amortized using the straight-line method over estimated useful lives.

(i)

Deferred Financing Costs

In November 2010, the Company entered into a senior secured revolving credit facility with Bank of America N.A. (“Senior Secured Revolving Credit Facility”) (see Note 10). The Company has incurred deferred financing costs of $8.5 million associated with the Senior Secured Revolving Credit Facility and related amendments, of which $251,000 and $1.4 million were incurred in the nine months ended September 30, 2014 and 2015, respectively. In the second quarter of 2015, the Company amended and restated the Senior Secured Revolving Credit Facility, which resulted in a loss on extinguishment of debt of approximately $274,000 for the write-off of unamortized deferred financing costs.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

In July 2011, the Company closed a private offering of $250.0 million in aggregate principal amount of 9.0% senior notes due 2019, which were subsequently registered through a public exchange offer (the “Senior Unsecured Notes”). The Company had incurred deferred financing costs of $7.1 million associated therewith, none of which were incurred in the three and nine months ended September 30, 2014 and 2015.

In April 2015, the Company completed a public offering of $500.0 million in aggregate principal amount of 5.625% senior unsecured notes due 2023 (the “Notes”). The Notes were issued at a price of 100% of their principal amount. The Notes are senior obligations of ExamWorks and are guaranteed by certain of ExamWorks’ existing and future U.S. subsidiaries. A portion of the gross proceeds of $500.0 million were used to repay all outstanding borrowings under the Senior Secured Revolving Credit Facility, to redeem all of the Senior Unsecured Notes, to pay related fees and expenses, and for general corporate purposes, including acquisitions. The Company has incurred deferred financing costs of $7.5 million relating to this offering, all of which were incurred in the nine months ended September 30, 2015.

In connection with the redemption of the Senior Unsecured Notes in May of 2015, the Company recorded debt extinguishment costs of $18.3 million of which $3.7 million related to unamortized deferred financing costs and $14.6 million related to a premium paid for the early redemption of the Senior Unsecured Notes.

The deferred financing costs associated with the Senior Secured Revolving Credit Facility and the Notes are being amortized to interest expense over the five-year term of the facility, as amended, and the eight-year term of the notes, respectively, using the straight-line method, which approximates the effective interest method.

The Company amortized $583,000 and $1.7 million for the three and nine months ended September 30, 2014, respectively and $380,000 and $1.4 million for the three and nine months ended September 30, 2015, respectively, to interest expense.

(j)

Revenue Recognition

Revenue related to IMEs, peer reviews, bill reviews, administrative support services and Medicare compliance services is recognized at the time services have been performed and the report is shipped to the end user. The Company believes that recognizing revenue at the time the report is shipped is appropriate because the Company’s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, Revenue Recognition: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

Revenue related to other IME services, including litigation support services, medical record retrieval services and case management services, where no report is generated, is recognized at the time the service is performed. The Company believes that recognizing revenue at the time the service is performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with ASC 605-10-S25, (i) persuasive evidence that arrangement exists, (ii) services have been rendered, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured.

Certain agreements with customers in the U.K. include provisions whereby collection of the amounts billed are contingent on the favorable outcome of the claim. The Company has deemed these provisions to preclude revenue recognition at the time of performance, as collectability is not reasonably assured and the cash payments are contingent, and is deferring these revenues, net of estimated costs, until the case has been settled, the contingency has been resolved and the cash has been collected. As of December 31, 2014 and September 30, 2015, the Company had $4.4 million and $3.0 million, respectively, in U.K. net deferred revenues associated with such agreements.

Should changes in conditions cause management to determine these criteria are not met for certain future transactions, revenue recognized for any subsequent reporting period could be adversely affected.

(k)

Costs of Revenues

Costs of revenues are comprised of fees paid to members of the Company’s medical panel; other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

l)	Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company applies the provisions of FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, (included in FASB ASC Subtopic 740-10, Income Taxes — Overall), and recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.

(m)

Income (Loss) Per Common Share

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during each period. Diluted income (loss) per common share is calculated by dividing net income (loss), adjusted on an “as if converted” basis, by the weighted-average number of actual shares outstanding and, when dilutive, the share equivalents that would arise from the assumed conversion of convertible instruments. The effect of potentially dilutive stock options, warrants, shares of restricted stock with service restrictions that have not yet been satisfied and unvested restricted stock units (“RSUs”) is calculated using the treasury stock method.

The following table sets forth basic and diluted net income per share computational data for the three and nine months ended September 30, 2014 and 2015 (amounts in thousands):

	Three months ended				Nine months ended
	September 30, 2014		September 30, 2015		September 30, 2014		September 30, 2015
Net income	$	3,415	$	7,155	$	6,658	$	1,316

Basic shares outstanding:
Common stock		39,251		41,384		38,259		40,936

Diluted shares outstanding:
Common stock		39,251		41,384		38,259		40,936
Dilutive securities (1)		2,396		1,774		2,638		2,045
Total		41,647		43,158		40,897		42,981

(1)

For the three and nine months ended September 30, 2014, the Company's dilutive securities exclude options potentially exercisable in the future into 96,000 shares and 78,000 shares, respectively, because their inclusion would have been anti-dilutive. For the three and nine months ended September 30, 2015, the Company's dilutive securities exclude options potentially exercisable in the future into 49,000 shares and 34,000 shares, respectively, because their inclusion would have been anti-dilutive.

(n)

Share-Based Compensation

The Company has an Amended and Restated 2008 Stock Incentive Plan, as amended, (the “Plan”) that provides for granting of stock options, restricted stock, RSUs and other equity awards. The Company accounts for share-based awards in accordance with ASC Topic 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires measurement of compensation cost for all share-based awards at fair value on the grant date (or measurement date if different) and recognition of compensation expense, net of forfeitures, over the requisite service period for awards expected to vest.

Stock Options

The fair value of stock option grants is determined using the Black-Scholes valuation model. The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable, characteristics not present in the Company’s stock options. Additionally, option valuation models require the input of highly subjective assumptions, including the expected volatility of the stock price. Because the Company’s stock options have characteristics significantly different from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimates, in management’s opinion, the existing models may not provide a reliable single measure of the fair value of its share-based awards. The Company’s expected volatility assumptions are based upon the weighted average of the Company’s implied volatility, the Company’s mean reversion volatility and the median of the Company’s peer group’s most recent historical volatilities for 2015 stock option grants. Expected life assumptions are based upon the “simplified” method for those options issued in 2015, which were determined to be issued approximately at-the-money. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

The assumptions utilized for stock option grants during the nine months ended September 30, 2015 were as follows:

	2015
Volatility			48.59%
Expected life (years)			6.00
Risk-free interest rate			2.01%
Dividend yield			—
Fair value		$19.30	–	$19.37

In the nine months ended September 30, 2015, the Company issued approximately 35,000 stock option awards to employees. The weighted average fair value of each stock option was $19.36 per option and the aggregate fair value was $678,000. All of these awards vest over a three-year period. Additionally, all of these options could vest earlier in the event of a change in control or merger or other acquisition. Share-based compensation expense related to stock option awards was $1.8 million and $6.5 million for the three and nine months ended September 30, 2014, respectively, of which $444,000 and $1.6 million, respectively, was included in costs of revenues, and $1.3 million and $4.9 million, respectively, was recorded in selling, general and administrative (“SGA”) expenses. Share-based compensation expense related to stock option awards was $1.0 million and $4.2 million for the three and nine months ended September 30, 2015, respectively, of which $259,000 and $987,000, respectively, was included in costs of revenues, and $778,000 and $3.2 million, respectively, was recorded in SGA expenses.

At September 30, 2015, the unrecognized compensation expense related to stock option awards was $5.9 million, with a remaining weighted average life of 1.5 years.

A summary of option activity for the nine months ended September 30, 2015 is as follows:

	Number of options			Weighted average exercise price		Weighted average remaining contractual life (years)		Aggregate intrinsic value (in thousands)
Outstanding at December 31, 2014		4,965,947		$	12.96
Options granted		35,000			40.20
Options forfeited		(49,881	)		22.96
Options exercised		(1,115,291	)		12.32
Outstanding at September 30, 2015		3,835,775		$	13.27

Exercisable at September 30, 2015		3,361,732		$	10.74		5.5	$	62,747

Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the weighted average exercise price multiplied by the number of options outstanding or exercisable. The total intrinsic value of stock options exercised was approximately $30.2 million during the nine months ended September 30, 2015.

Restricted Stock and Restricted Stock Units

The Company has granted members of the Board of Directors, certain employees and outside consultants, time lapse restricted stock and RSUs which vest after a stipulated number of years from the grant date depending on the terms of the issue. The fair value of shares of restricted stock and RSUs is determined based upon the market price of the underlying common stock as of the date of grant. Time lapse restricted shares issued and RSUs vest over one to five-year periods. The agreements under which the restricted stock and RSUs are issued provide that shares awarded may not be sold or otherwise transferred until restrictions established under the stock plans have been satisfied. The restriction on a majority of these awards could expire earlier than the stipulated time frame in the event of a change in control or merger or other acquisition. Share-based compensation expense related to shares of restricted stock and RSUs was $2.1 million and $6.4 million for the three and nine months ended September 30, 2014, respectively, all of which is included in SGA expenses. Share-based compensation expense related to shares of restricted stock and RSUs was $4.4 million and $13.2 million for the three and nine months ended September 30, 2015, respectively, all of which is included in SGA expenses.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

The following is a summary of resticted share and RSU activity for the nine months ended September 30, 2015:

	Number of awards			Weighted average grant date fair value
Non-vested awards at December 31, 2014		880,433		$	25.46
Awards granted		823,601			40.30
Awards vested		(447,168	)		27.46
Awards forfeited		(22,923	)		33.42
Non-vested awards at September 30, 2015		1,233,943		$	34.49

The total fair value of vested RSUs and shares of restricted stock during the nine months ended September 30, 2015 was $12.3 million. At September 30, 2015, total unrecognized compensation costs related to non-vested restricted shares and RSUs was $31.6 million which is expected to be recognized over a weighted average period of 2.0 years.

During the three and nine months ended September 30, 2014, the Company recorded share-based compensation expense of $790,000 and $1.8 million, respectively, related to annual incentive compensation plans established by the Compensation Committee of the Board of Directors, all of which was recorded in SGA expenses. During the nine months ended September 30, 2015, the Company recorded share-based compensation expense of $777,000 related to annual incentive compensation plans established by the Compensation Committee of the Board of Directors, all of which was recorded in SGA expenses. The 2014 obligation was settled in March 2015 via the issuance of approximately 122,000 shares of restricted stock, and the 2015 plan year obligation is recorded as accrued expenses in the accompanying Consolidated Balance Sheets. The 2015 incentive compensation plan contains a performance metric based on the Company’s 2015 financial performance and a subsequent time-based service requirement. If the performance metric is met, the associated liability will be settled in the first quarter of 2016 with the granting of an indeterminate number of restricted shares which will vest equally on June 1, 2016 and 2017.

(o)

Fair Value Measurements

The Company’s financial assets and (liabilities), which are measured at fair value on a recurring basis, are categorized using the fair value hierarchy at December 31, 2014 and September 30, 2015, and are as follows (in thousands):

	Level 1		Level 2		Level 3			Total
As of December 31, 2014
Financial instruments:
Contingent consideration	$	—	$	—	$	(6,587	)	$	(6,587	)
Foreign currency derivative asset		—		272		—			272

As of September 30, 2015
Financial instruments:
Foreign currency derivative asset	$	—	$	2,351	$	—		$	2,351

The contingent consideration relates to earnout provisions recorded in conjunction with certain acquisitions completed in 2013 and 2014 (see Note 3). Of the total decrease in fair value of the contingent consideration of $6.6 million in 2015, $5.1 million was settled as cash consideration to satisfy installments related to a 2013 and 2014 acquisition and the Company recorded $1.5 million in adjustments to the fair value of the obligation related to milestones which were not achieved, or expected to be achieved, recorded to SGA expenses, offset by $162,000 recorded in interest and other expenses, net in the Consolidated Statements of Comprehensive Income (Loss) due to changes in the fair value of the contingent consideration and the remaining change is due to currency fluctuations.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES
Notes to Consolidated Financial Statements

(Unaudited)

The fair value of the foreign currency derivative was determined using observable market inputs such as foreign currency exchange rates and considers nonperformance risk of the Company and that of its counterparties.

(p)

Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) refers to revenues, expenses, gains and losses that under U.S. GAAP are recorded as a component of stockholders’ equity but are excluded from net income (loss). The Company’s accumulated other comprehensive income (loss) consists of foreign currency translation adjustments, reported net of tax as appropriate, from those subsidiaries not using the U.S. dollar as their functional currency and unrealized gains and losses, reported net of tax as appropriate, resulting from its net investment hedge of its Australian and U.K. subsidiaries. Accumulated other comprehensive income (loss) consists of the following (in thousands):

	Foreign Currency Translation			Net investment hedge - foreign exchange contract			Total
Balance at December 31, 2014	$	(17,821	)	$	3,445		$	(14,376	)
Change during 2015:
Before-tax amount		(18,818	)		6,201			(12,617	)
Tax (expense) benefit		6,399			(2,452	)		3,947
Total activity in 2015		(12,419	)		3,749			(8,670	)
Balance at September 30, 2015	$	(30,240	)	$	7,194		$	(23,046	)

(q)

Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In April 2014, the FASB issued ASU No. 2014-08, (Topic 205 and 360), “Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity” (“ASU 2014-08”) which amends the definition for what types of asset disposals are to be considered discontinued operations, and amends the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 also enhances the convergence of the FASB’s and the International Accounting Standard Board’s reporting requirements for discontinued operations. The amendments in this update are effective for fiscal periods beginning on or after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. The Company adopted the provisions of this standard effective January 1, 2015 and the adoption of these provisions did not have a material impact on its financial position, results of operations and cash flows.

Accounting Pronouncements Not Yet Adopted

In May 2014, the FASB issued ASU No. 2014-09, (Topic 606): Revenue from Contracts with Customers (“ASU 2014-09”) which supersedes the revenue recognition requirements in “Topic 605, Revenue Recognition” and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective retrospectively for annual or interim reporting periods beginning after December 15, 2017, with early application not permitted. The Company is currently evaluating the impact of this standard on its financial position, results of operations and cash flows.

In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-05”) which defines management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. Currently, financial statements are prepared under the presumption that the reporting organization will continue to operate as a going concern, except in limited circumstances. This going concern basis of accounting is critical to financial reporting because it establishes the fundamental basis for measuring and classifying assets and liabilities. ASU 2014-05 provides guidance regarding management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern and the related footnote disclosures. The amendments are effective for the year ending December 31, 2016, and for interim periods beginning the first quarter of 2017, with early application permitted. The Company plans to adopt the provisions for the year ending December 31, 2016 and will provide such disclosures as required if there are conditions and events that raise substantial doubt about its ability to continue as a going concern. The Company currently does not expect the adoption to have a material impact on its consolidated financial statements.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

In April 2015, the FASB issued ASU No. 2015-03, “Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”) which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in ASU 2015-03. The amendments in this update are effective for fiscal periods beginning on or after December 15, 2015, and interim periods within those fiscal years. The Company is currently evaluating the impact of this standard on its financial position, results of operations and cash flows.

In September 2015, the FASB issued ASU No. 2015-16, “Business Combinations (Topic 805) Simplifying the Accounting for Measurement-Period Adjustments” which requires that an acquirer recognize adjustments to estimated amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments also require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the estimated amounts had been recognized as of the acquisition date. The amendments in this update are effective for fiscal periods beginning on or after December 15, 2015, and interim periods within those fiscal years. The Company plans to adopt the provisions for the year ending December 31, 2016 and currently does not expect the adoption to have a material impact on its consolidated financial statements.

There were various other accounting standards and interpretations issued during 2014 and 2015 the Company has not yet been required to adopt, none of which are expected to have a material impact on its financial position, results of operations and cash flows.

(3)

Acquisitions

ExamWorks operates in a highly fragmented industry and as of September 30, 2015 has completed 52 acquisitions since July 14, 2008. A key component of ExamWorks’ acquisition strategy is growth through acquisitions that expand its geographic coverage, that provide new or complementary lines of business, expand its portfolio of services and that increase its market share.

The Company has accounted for all business combinations using the purchase method to record a new cost basis for the assets acquired and liabilities assumed. The Company recorded, based on a preliminary purchase price allocation, intangible assets representing client relationships, tradenames, covenants not to compete, technology and the excess of purchase price over the estimated fair value of the tangible assets acquired and liabilities assumed as goodwill in the accompanying consolidated financial statements. The goodwill is attributable to synergies achieved through the streamlining of operations combined with improved margins attainable through increased market presence. The results of operations are reflected in the consolidated financial statements of the Company from the date of acquisition.

(a)

2014 Acquisitions

In 2014, the Company completed the following individually insignificant acquisitions, as defined in SEC Regulation S-X Rule 3-05, with an aggregate purchase price of $194.8 million, comprised of $189.0 million cash consideration less cash acquired of $1.1 million, and $6.9 million of contingent consideration. In conjunction with these 2014 acquisitions, the Company incurred aggregate transaction costs of $1.6 million, of which $186,000 and $916,000 was incurred in the three and nine months ended September 30, 2014, respectively. The Company did not incur any costs associated with the indicated acquisitions in the first three quarters of 2015. These amounts are reported in SGA expenses in the Company’s accompanying Consolidated Statements of Comprehensive Income (Loss). These acquisitions enhanced and expanded the presence and service offerings of the Company.

Company name	Form of acquisition	Date of acquisition
Newton Medical Group (United States)	Substantially all of the assets and assumed certain liabilities	January 13, 2014
Cheselden (United Kingdom)	100% of the outstanding share capital	January 16, 2014
G&L Intermediate Holdings (“Gould & Lamb”) (United States)	100% of the outstanding common stock	February 3, 2014
Assess Medical Group Pty Ltd (Australia)	100% of the outstanding common stock	February 14, 2014
Solomon Associates (United States)	Substantially all of the assets and assumed certain liabilities	May 30, 2014
Ability Services Network (United States)	100% of the outstanding common stock	June 6, 2014
Expert Medical Opinions (United States)	Substantially all of the assets and assumed certain liabilities	August 22, 2014

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

The preliminary allocation of consideration for these acquisitions is summarized as follows (in thousands):

	Preliminary purchase price allocation December 31, 2014			Adjustments/ reclassifications			Preliminary purchase price allocation September 30, 2015
Equipment and leasehold improvements		886			—			886
Customer relationships		50,216			—			50,216
Tradenames		10,342			—			10,342
Covenants not to compete		590			—			590
Technology		1,870			—			1,870
Goodwill		136,034			470			136,504
Net deferred tax liability associated with step-up in book basis		(9,041	)		—			(9,041	)
Assets acquired and liabilities assumed, net		3,785			(379	)		3,406
Totals		194,682			91			194,773

In 2015, the Company recorded adjustments to working capital resulting in an increase in total consideration paid of $91,000. Goodwill of $116.5 million and other intangible assets of $36.7 million are expected to be deductible for U.S. federal income tax purposes, a portion of which are subject to the provisions of IRC Section 901(m) which contain certain foreign tax credit limitations. The Company believes that information gathered to date provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed but the Company is waiting for additional information necessary to finalize those fair values. Thus, the provisional measurements of fair value set forth above are subject to change. Such changes are not expected to be significant. The Company expects to complete the purchase price allocation as soon as practicable but no later than one year from the acquisition date.

(b)

2015 Acquisitions

In 2015, the Company completed the following individually insignificant acquisitions, as defined in SEC Regulation S-X Rule 3-05, with an aggregate purchase price of $11.9 million, comprised of $12.6 million cash consideration less cash acquired of $655,000. In conjunction with the 2015 acquisitions, the Company incurred aggregate transaction costs of $170,000, of which $35,000 were incurred in the nine months ended September 30, 2015. These amounts are reported in SGA expenses in the Company’s accompanying Consolidated Statements of Comprehensive Income (Loss). These acquisitions enhanced and expanded the presence and service offerings of the Company.

Company name	Form of acquisition	Date of acquisition
ReliableRS (United States)	Substantially all of the assets and assumed certain liabilities	January 2, 2015
Landmark Exams & Maven Exams (United States)	Substantially all of the assets and assumed certain liabilities	April 14, 2015
Karen Rucas & Associates (Canada)	Substantially all of the assets and assumed certain liabilities	July 13, 2015

The preliminary allocation of consideration for these acquisitions is summarized as follows (in thousands):

	Preliminary purchase price allocation September 30, 2015
Equipment and leasehold improvements	$	79
Customer relationships		4,465
Tradename		1,065
Covenants not to compete		182
Goodwill		5,208
Assets acquired and liabilities assumed, net		904
Total	$	11,903

Goodwill of $5.0 million and other intangible assets of $5.4 million are expected to be deductible for U.S. federal income tax purposes. The Company believes that information gathered to date provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed but the Company is waiting for additional information necessary to finalize those fair values. Thus, the provisional measurements of fair value set forth above are subject to change. Such changes are not expected to be significant. The Company expects to complete the purchase price allocation as soon as practicable but no later than one year from the acquisition date. The 2015 acquisitions contributed $2.5 million in revenues and $27,000 in operating loss and $5.9 million in revenues and $809,000 in operating income for the three and nine months ended September 30, 2015, respectively.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(c)

Pro forma Financial Information

The following unaudited pro forma results of operations for the three and nine months ended September 30, 2014 and 2015 assumes that the 2014 acquisitions were completed on January 1, 2013 and the 2015 acquisitions were completed on January 1, 2014.

For the three and nine months ended September 30, 2014, the pro forma results include adjustments to reflect (reduced) additional interest and other expenses, net of $(191,000) and $45,000, respectively, associated with the payoff or funding of the acquisitions assuming that acquisition related debt was incurred on those referenced above. In addition, incremental depreciation and amortization expense was recorded as if the acquisitions had occurred on the dates referenced above and amounted to $490,000 and $4.6 million, respectively, for the three and nine months ended September 30, 2014. Finally, adjustments of $237,000 and $6.4 million were made to reduce SGA expenses for the three and nine months ended September 30, 2014, respectively, principally related to certain salary and other personal expenses attributable to the previous owners of the acquired businesses. These adjustments represent contractual reductions and are considered to be non-recurring and are not expected to have a continuing impact on the operations of the Company.

For the nine months ended September 30, 2015, the pro forma results include adjustments to reflect additional interest and other expenses of $82,000 associated with the funding of the acquisitions assuming that acquisition related debt was incurred on those referenced above. In addition, incremental depreciation and amortization expense was recorded as if the acquisitions had occurred on the dates referenced above and amounted to $3,000 and $389,000 for the three and nine months ended September 30, 2015, respectively. Finally, adjustments of $(28,000) and $401,000 were made to (reduce) and increase SGA expenses for the three and nine months ended September 30, 2015, respectively, principally related to certain salary and other personal expenses attributable to the previous owners of the acquired businesses. These adjustments represent contractual reductions or increases and are considered to be non-recurring and are not expected to have a continuing impact on the operations of the Company.

	Three months ended September 30,				Nine months ended September 30,
	2014		2015		2014		2015
	(In thousands, except per share data)
Pro forma revenues	$	207,701	$	206,080	$	605,755	$	614,306
Pro forma net income		3,282		7,152		7,116		1,367
Pro forma income per share: Basic	$	0.08	$	0.17	$	0.19	$	0.03
Pro forma income per share: Diluted	$	0.08	$	0.17	$	0.17	$	0.03

The pro forma financial information presented above is not necessarily indicative of either the results of operations that would have occurred had the acquisitions been effective as of January 1 of the respective years or of future operations of the Company.

(4)

Property, Equipment and Leasehold Improvements

Property, equipment and leasehold improvements at December 31, 2014 and September 30, 2015, consist of the following (in thousands):

	Estimated useful lives (years)			December 31, 2014		September 30, 2015
Building		15		$	2,553	$	2,661
Computer and office equipment		3			19,161		19,972
Furniture and fixtures	3	to	5		4,274		4,836
Leasehold improvements	Lease term				4,836		5,672
					30,824		33,141
Less accumulated depreciation and amortization					15,098		16,063
Totals				$	15,726	$	17,078

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

Depreciation expense was $1.7 million and $4.7 million for the three and nine months ended September 30, 2014, respectively. Depreciation expense was $1.7 million and $5.0 million for the three and nine months ended September 30, 2015, respectively.

(5)

Goodwill and Intangible Assets

Goodwill by segment at December 31, 2014 and September 30, 2015 consists of the following (in thousands) (1):

	United States		Canada			United Kingdom			Australia			Total
Balance at December 31, 2014	$	401,560	$	17,178		$	38,354		$	38,587		$	495,679
Goodwill acquired during the year		5,063		145			—			—			5,208
Adjustments to prior year acquisitions		470		—			—			—			470
Effect of foreign currency translation		—		(3,143	)		(982	)		(7,700	)		(11,825	)
Balance at September 30, 2015	$	407,093	$	14,180		$	37,372		$	30,887		$	489,532

(1)

Goodwill recorded in connection with certain tax benefits to be realized in the Company’s U.S. income tax returns has been reflected in the United States segment.

Intangible assets at December 31, 2014 and September 30, 2015, consist of the following (in thousands):

				December 31, 2014
	Estimated useful lives (months)			Gross carrying amount		Accumulated amortization			Net carrying value
Amortizable intangible assets:
Customer relationships	40	to	60	$	244,211	$	(167,943	)	$	76,268
Tradenames	45	to	84		68,264		(45,901	)		22,363
Covenants not to compete		36			6,761		(4,116	)		2,645
Technology	24	to	40		9,188		(7,881	)		1,307
Totals				$	328,424	$	(225,841	)	$	102,583

				September 30, 2015
	Estimated useful lives (months)			Gross carrying amount		Accumulated amortization			Net carrying value
Amortizable intangible assets:
Customer relationships	40	to	60	$	239,793	$	(190,290	)	$	49,503
Tradenames	45	to	84		67,242		(50,549	)		16,693
Covenants not to compete		36			10,028		(5,520	)		4,508
Technology	24	to	40		9,061		(8,269	)		792
Totals				$	326,124	$	(254,628	)	$	71,496

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

The aggregate intangible amortization expense was $14.0 million and $40.2 million for the three and nine months ended September 30, 2014, respectively. The aggregate intangible amortization expense was $11.3 million and $36.6 million for the three and nine months ended September 30, 2015, respectively. The estimated future amortization expense of intangible assets is as follows (in thousands):

	Amount
Three months ended December 31, 2015	$	11,210
Years ended December 31:
2016		34,205
2017		21,962
2018		3,126
2019		993
Total	$	71,496

(6)

Accrued Expenses

Accrued expenses at December 31, 2014 and September 30, 2015 consist of the following (in thousands):

	December 31, 2014		September 30, 2015
Accrued compensation and benefits	$	15,041	$	14,769
Accrued selling and professional fees		4,202		3,557
Accrued income, value added and other taxes		26,576		28,248
Accrued medical panel fees		4,391		4,644
Other accrued expenses		3,768		3,056
Totals	$	53,978	$	54,274

(7)

Stockholders’ Equity

During the nine months ended September 30, 2015, the Company issued approximately 1,107,000 shares of common stock to settle options exercised during the period.

During the nine months ended September 30, 2015, the Company issued approximately 20,000 shares of common stock to settle warrants exercised during the period.

During the nine months ended September 30, 2015, the Company issued approximately 91,000 shares of restricted stock with a fair value of $3.7 million to certain officers and employees for services to be provided during the next three years. The Company is recording the expenses related to these awards in SGA expenses over the requisite service period.

During the nine months ended September 30, 2015, the Company issued approximately 16,000 shares of restricted stock with a fair value of $555,000 to the members of the Board of Directors as compensation for services to be provided during the next year. The Company records the expenses related to these awards in SGA expenses over the requisite service period.

During the nine months ended September 30, 2015, the Company issued approximately 220,000 shares of common stock to settle restricted stock units whose restrictions were lifted during the period.

During the nine months ended September 30, 2015, the Company issued approximately 122,000 shares of restricted stock to certain officers and employees in settlement of its 2014 incentive compensation plan liability. The first 50% restriction on these shares was lifted on June 1, 2015 and the remaining 50% restriction will be lifted on June 1, 2016. The Company records the remaining expense related to these awards in SGA expenses over the remaining service period.

During the nine months ended September 30, 2015, the Company did not repurchase any shares under the share repurchase program. As of September 30, 2015, the Company has approximately 905,000 shares of common stock held as treasury shares with an average value of $9.38 per share, and the ability to repurchase an additional $10.2 million in shares of its common stock.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(8)

Related Party Transactions

The Senior Secured Revolving Credit Facility contains a provision requiring the Company to use a third party to perform financial due diligence for acquisitions exceeding a certain size. With the approval of the senior lender, the Company engaged RedRidge Finance Group (“RedRidge”) to assist it with financial due diligence and incurred $9,000 and $300,000 in fees, pertaining to acquisition-related work performed during the three and nine months ended September 30, 2014, respectively. The Company incurred $132,000 and $250,000 in fees pertaining to acquisition-related work performed during the three and nine months ended September 30, 2015, respectively. P&P Investment, LLC (“P&P”), a company owned by Richard Perlman and James Price, the Executive Chairman and Chief Executive Officer, respectively, of the Company, is a minority owner and lender of RedRidge.

(9)

Commitments and Contingencies

(a)

Lease Commitments

The Company and its subsidiaries lease office space and office related equipment under noncancelable operating leases with various expiration dates from 2015 through 2023.

Future minimum lease payments under the operating leases for the three months ended December 31, 2015 and in each of the years subsequent to December 31, 2015 are as follows (in thousands):

	Amount
Three months ended December 31, 2015	$	3,529
Years ended December 31:
2016		13,235
2017		11,814
2018		9,562
2019		6,588
Thereafter		6,987
Total	$	51,715

Related rent expense was $3.9 million and $11.1 million for the three and nine months ended September 30, 2014, respectively. Related rent expense was $4.4 million and $13.1 million for the three and nine months ended September 30, 2015, respectively.

(b)

Employee Benefit Plans

The Company and certain of its subsidiaries each sponsor separate voluntary defined contribution pension plans. The plans cover employees that meet specific age and length of service requirements. The Company and certain of its subsidiaries have various matching and vesting arrangements within their individual plans. For the three and nine months ended September 30, 2014, the Company recorded $230,000 and $691,000, respectively, in compensation expense related to these plans. For the three and nine months ended September 30, 2015, the Company recorded $245,000 and $921,000, respectively, in compensation expense related to these plans.

(10)

Long-Term Debt

Long-term debt at December 31, 2014 and September 30, 2015 consists of the following (in thousands):

	December 31, 2014		September 30, 2015
Senior Unsecured Notes Payable (a)	$	250,000	$	500,000
Senior Secured Revolving Credit Facility, Bank of America, N.A. (b)		143,853		—
Working capital facilities, Barclays (c)		40,396		38,838
		434,249		538,838
Less current portion		40,396		—
	$	393,853	$	538,838

(a) In July 2011, and through June 2012, the Company closed the offering of the Senior Unsecured Notes. The Senior Unsecured Notes were issued at a price of 100% of their principal amount. A portion of the gross proceeds of $250.0 million were used to repay borrowings outstanding under the Company’s Senior Secured Revolving Credit Facility and pay related fees and expenses, and the remainder was used for general corporate purposes, including acquisitions.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

On April 16, 2015, the Company closed a public offering of the Notes. The Notes were issued at a price of 100% of their principal amount. The Notes are senior obligations of ExamWorks and are guaranteed by certain of ExamWorks’ existing and future U.S. subsidiaries. The gross proceeds of $500.0 million were used to repay all outstanding borrowings under the Senior Secured Revolving Credit Facility, to redeem all of the Senior Unsecured Notes, to pay related fees and expenses, and for general corporate purposes, including acquisitions.

The Notes were issued under an indenture, dated as of April 16, 2015, as supplemented by a supplemental indenture, dated April 16, 2015 (collectively, the “Indenture”), among the Company, the Guarantors and U.S. Bank, National Association, as trustee (the “Trustee”). The Notes are the Company’s general senior unsecured obligations, and rank equally with the Company’s existing and future senior unsecured obligations and senior to all of the Company’s further subordinated indebtedness. The Notes accrue interest at a rate of 5.625% per year, payable semi-annually in cash in arrears on April 15 and October 15 of each year, commencing October 15, 2015. Interest accrues from the issue date of the Notes.

At any time on or after April 15, 2018, the Company may redeem some or all of the Notes at the redemption prices specified in the Indenture, plus accrued and unpaid interest to the date of redemption. Prior to April 15, 2018, the Company may redeem up to 40% of the aggregate principal amount of the Notes with the net cash proceeds from certain equity offerings at a redemption price equal to 105.625% of the aggregate principal amount of the Notes, plus accrued and unpaid interest, if any, provided that at least 60% of the original aggregate principal amount of the Notes remains outstanding after redemption. In addition, the Company may redeem some or all of the Notes at any time prior to April 15, 2018 at a redemption price equal to 100% of the principal amount of the Notes plus a make whole premium described in the Indenture, plus accrued and unpaid interest.

The Indenture includes covenants which, subject to certain exceptions, limit the ability of the Company and its restricted subsidiaries (as defined in the Indenture) to, among other things, incur additional indebtedness, make certain types of restricted payments, incur liens on assets of the Company or the restricted subsidiaries, engage in asset sales and enter into transactions with affiliates. Upon a change of control (as defined in the Indenture), the Company may be required to make an offer to repurchase the Notes at 101% of their principal amount, plus accrued and unpaid interest. The Indenture also contains customary events of default.

(b) On November 2, 2010, the Company entered into the Senior Secured Revolving Credit Facility with Bank of America, N.A. The facility initially consisted of a $180.0 million revolving credit facility. The facility is available to finance the Company’s acquisition program and working capital needs.

On April 16, 2015, the Company amended and restated the terms of its Senior Secured Revolving Credit Facility in connection with the offering of the Notes pursuant to an amended and restated credit agreement (the “Amended and Restated Credit Facility”) dated April 16, 2015. The Amended and Restated Credit Facility provides for up to $300.0 million of revolving extensions of credit outstanding at any time (including revolving loans, swingline loans and letters of credit). During the term of the Amended and Restated Credit Facility, the Company has the right, subject to compliance with the covenants specified in the Amended and Restated Credit Facility and the Notes, to increase the revolving extensions under the Amended and Restated Credit Facility to a maximum of $400.0 million. The term of the Senior Secured Revolving Credit Facility was extended for five years from the date of the amendment to April 2020.

Borrowings under the Senior Secured Revolving Credit Facility, as amended, bear interest, at either (i) LIBOR plus the applicable margin or (ii) a base rate (equal to the highest of (a) the federal funds rate plus 0.5%, (b) the Bank of America prime rate and (c) LIBOR (using a one-month period) plus 1.0%), plus the applicable margin, as the Company elects. The applicable margin means a percentage per annum determined in accordance with the following table:

Pricing Tier	Consolidated Senior Secured Leverage Ratio					Commitment Fee/Unused Line Fee			Letter of Credit Fee			Eurocurrency Rate Loans			Base Rate Loans
1	≥	4.00	to 1.0				0.45	%		2.75	%		2.75	%		1.75	%
2	≥	3.50	to 1.0 but <	4.00	to 1.0		0.40	%		2.50	%		2.50	%		1.50	%
3	≥	3.00	to 1.0 but <	3.50	to 1.0		0.35	%		2.25	%		2.25	%		1.25	%
4	≥	2.50	to 1.0 but <	3.00	to 1.0		0.30	%		2.00	%		2.00	%		1.00	%
5			<	2.50	to 1.0		0.30	%		1.75	%		1.75	%		0.75	%

In the event of default, the outstanding indebtedness under the facility will bear interest at an additional 2%.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

The Senior Secured Revolving Credit Facility contains restrictive covenants, including among other things financial covenants requiring the Company to not exceed a maximum consolidated senior secured leverage coverage ratio, a maximum total consolidated leverage ratio and to maintain a minimum consolidated fixed charge coverage ratio. The Senior Secured Revolving Credit Facility also restricts the Company’s ability (subject to certain exceptions) to incur indebtedness, prepay or amend other indebtedness, create liens, make certain fundamental changes including mergers or dissolutions, pay dividends and make other payments in respect of capital stock, make certain investments, sell assets, change its lines of business, enter into transactions with affiliates and other corporate actions.

On June 1, 2015 the Company entered into a first amendment to the Senior Secured Revolving Credit Facility (“First Amendment”). The First Amendment amended the definition of “Change of Control” in the Senior Secured Revolving Credit Facility.

As of September 30, 2015, the Company had no amount outstanding under the Senior Secured Revolving Credit Facility, resulting in $300.0 million of undrawn commitments.

(c) On September 29, 2010, the Company’s indirect 100% owned subsidiary UK Independent Medical Services Limited (“UKIM”) entered into a Sales Finance Agreement (the “UKIM SFA”) with Barclays Bank PLC (“Barclays”), pursuant to which Barclays provides UKIM a working capital facility of up to £5,000,000, subject to the terms and conditions of the UKIM SFA. The working capital facility bore a discount margin of 2.5% over Base Rate and served to finance UKIM’s unpaid account receivables. The working capital facility had a minimum term of 36 months.

On June 28, 2013, UKIM entered into an amendment to extend the term of the existing UKIM SFA by 24 months from June 28, 2013, to amend the discount margin to 2.4% over Base Rate (0.5% rate on September 30, 2015) and to provide that payments by UKIM for certain non-working capital purposes are permitted under the UKIM SFA. Further, on April 16, 2015, UKIM entered into an amendment to extend the term of the existing UKIM SFA for an additional 36 months from the amendment date. The working capital facility operates on a co-terminus and cross-default basis with other facilities provided by Barclays and with the Senior Secured Revolving Credit Facility. As of September 30, 2015, UKIM had $6.9 million outstanding under the working capital facility, resulting in approximately $699,000 in availability.

On May 12, 2011, the Company’s indirect 100% owned subsidiary Premex Group Limited (“Premex”) entered into a Sales Finance Agreement (the “Premex SFA”) with Barclays, pursuant to which Barclays provides Premex a working capital facility of up to £26,500,000, subject to the terms and conditions of the Premex SFA. The working capital facility bears a discount margin of 2.4% over Base Rate (0.5% rate on September 30, 2015) and serves to finance Premex’s unpaid account receivables. The working capital facility had a minimum term of 36 months.

On June 28, 2013, Premex entered into an amendment to extend the term of the existing Premex SFA by 24 months from June 28, 2013, and to provide that payments by Premex for certain non-working capital purposes are permitted under the Premex SFA. Further, on April 16, 2015, Premex entered into an amendment to extend the term of the existing Premex SFA for an additional 36 months from the amendment date. The working capital facility operates on a co-terminus and cross-default basis with other facilities provided by Barclays and with the Senior Secured Revolving Credit Facility. As of September 30, 2015, Premex had $32.0 million outstanding under the working capital facility, resulting in approximately $8.2 million in availability.

As of September 30, 2015, future maturities of long-term debt were as follows (in thousands):

	Amount
Three months ended December 31, 2015	$	—
Years ended December 31:
2016		—
2017		—
2018		38,838
2019		—
Thereafter		500,000
Total	$	538,838

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(11)

Financial Instruments

The FASB issued ASC Topic 815, Derivatives and Hedging (“ASC 815”) which establishes accounting and reporting standards for derivative instruments. ASC 815 requires an entity to recognize all derivatives as either assets or liabilities and measure those instruments at fair value. Derivatives that do not qualify as a hedge must be adjusted to fair value in earnings. If the derivative does qualify as a hedge under ASC 815, changes in the fair value will either be offset against the change in fair value of the hedged assets, liabilities or firm commitments or recognized in accumulated other comprehensive income (loss) until the hedged item is recognized in earnings. The ineffective portion of a hedge’s change in fair value will be immediately recognized in earnings.

Beginning in the second quarter of 2013, in order to protect against foreign currency exposure in its Australian operations, the Company entered into forward foreign currency contracts as a hedge of AUD $60.0 million of its net investment in Australia. Beginning in the third quarter of 2013, the Company also entered into forward foreign currency contracts as a hedge of £40.0 million of its net investment in the U.K. The Company settled certain of its hedge positions during the 2015 year and received $4.1 million in net proceeds. This amount was classified in accumulated other comprehensive loss in the Company’s Consolidated Balance Sheet (see Note 2), offsetting the currency translation adjustment of the related net investment that is also recorded in accumulated other comprehensive loss, and is reported net of the effect of income taxes.

As of December 31, 2014, the Company had a net asset of $272,000 recorded in other current liabilities with the offsetting net unrealized gain being recorded in accumulated other comprehensive loss in its Consolidated Balance Sheets associated with open forward foreign currency contracts which matured in January of 2015. As of September 30, 2015, the Company had a gross asset of $2.4 million recorded in other current assets, with the offsetting net unrealized gain being recorded in accumulated other comprehensive income (loss) in its Consolidated Balance Sheets associated with open forward foreign currency contracts which matured in October of 2015.

The Company does not enter into derivative transactions for speculative purposes.

(12)

Income Taxes

In preparing its consolidated financial statements, the Company estimates income taxes in each of the jurisdictions in which it operates. This process involves estimating actual current tax exposure together with assessing temporary differences resulting from differing treatment of items for tax and financial reporting purposes. These differences result in deferred income tax assets and liabilities.

Additionally, the Company currently has significant deferred tax assets and other deductible temporary differences including basis differences between intangible assets. The Company does not provide a valuation allowance against its deferred tax assets as the Company believes that it is more likely than not that all of the deferred tax assets will be realized based on available evidence including scheduled reversal of deferred tax liabilities, projected future taxable income and other tax planning considerations.

The Company applies the provisions of ASC 740 as it relates to uncertain tax positions. This interpretation prescribes a comprehensive model for how a company should recognize, measure, present and disclose in its financial statements uncertain tax positions that the company has taken or expects to take on a tax return. ASC 740 states that a tax benefit from an uncertain tax position may be recognized only if it is “more likely than not” that the position is sustainable, based on its technical merits. The tax benefit of a qualifying position is the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement with a taxing authority having full knowledge of all relevant information. The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense.

The following table summarizes the activity related to the unrecognized tax benefits for the nine months ended September 30, 2015, (in thousands)

Balance at January 1, 2015	$	1,593
Increase to prior year tax positions		(26	)
Increase to current year tax positions		70
Expiration of the statute of limitations for the assessment of taxes		(281	)
Decrease related to settlements		—
Balance at September 30, 2015	$	1,356

The Company is no longer subject to U.S. federal income and state tax return examinations by tax authorities for tax years before 2010 and 2009, respectively. The Company operates in multiple taxing jurisdictions and faces audits from various tax authorities. The Company remains subject to examination until the statute of limitations expires for the respective tax jurisdiction. The Company does not anticipate that the amount of the unrecognized benefit will significantly increase or decrease within the next 12 months.

Undistributed earnings of the Company’s foreign subsidiaries are considered indefinitely reinvested and, accordingly, no provision for U.S. federal income taxes has been recorded. Deferred taxes are provided for earnings outside the United States when those earnings are not considered indefinitely reinvested.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(13)

Segment and Geographical Information

The Company applies the provisions of ASC Topic 280, Segment Reporting, (“ASC 280”). ASC 280, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products, major customers and the geographies in which the entity holds material assets and reports revenue. An operating segment is defined as a component that engages in business activities whose operating results are reviewed by the chief operating decision maker (“CODM”) and for which discrete financial information is available. Based on the provisions of ASC 280, the Company has determined that it operates in four geographic segments: the United States, Canada, the United Kingdom and Australia. The CODM evaluates segment performance based on revenues and segment profit, as defined below. The Company’s corporate costs and assets are all incurred in the United States and are included in the United States segment, as this is consistent with how they are presented and reviewed by the CODM. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies.

Information relating to the Company’s product groups (IMEs, peer review, bill review, Medicare compliance, case management and other related services) is as follows (in thousands):

Revenues:	For the three months ended September 30,				For the nine months ended September 30,
	2014		2015		2014		2015
IME and other related services (1)	$	174,012	$	173,866	$	501,520	$	516,699
Peer and bill reviews, Medicare compliance services and case management services (1)		30,066		32,167		72,031		94,388
Total revenues	$	204,078	$	206,033	$	573,551	$	611,087

(1)

Includes the results of certain of the Company’s service centers acquired whose revenues are generated substantially through the indicated product group. Outside of this presentation, other product groups are not tracked within the Company’s financial systems. Additionally, other related services, which include any Medicare compliance services and case management services completed at the Company’s historic service centers in the periods presented, are not separately captured within the Company’s financial systems and have been included with IME services in the above presentation as separate presentation is not practicable. With the Company’s acquisition of Gould & Lamb in February of 2014 and Ability Services Network and MedAllocators in June of 2014, Medicare compliance services and case management services have been added to the presentation above. None of the individual services within the peer and bill reviews, Medicare compliance services and case management services category above represent more than 10% of consolidated revenues.

EXAMWORKS GROUP, INC. AND SUBSIDARIES

Notes to Consolidated Financial Statements

(Unaudited)

Information relating to the Company’s geographic segments is as follows (in thousands)(1):

	United States			Canada			United Kingdom			Australia			Total
Three months ended September 30, 2014
Revenues	$	123,112		$	8,075		$	48,865		$	24,026		$	204,078
Segment profit		21,187			842			8,154			5,900			36,083
Depreciation and amortization expense		9,148			685			2,962			2,910			15,705
Capital expenditures		(1,305	)		(3	)		(505	)		(769	)		(2,582	)

Nine months ended September 30, 2014
Revenues	$	346,504		$	24,160		$	139,583		$	63,304		$	573,551
Segment profit		57,770			3,105			23,613			14,184			98,672
Depreciation and amortization expense		25,037			2,207			9,230			8,431			44,905
Capital expenditures		(4,169	)		(12	)		(1,022	)		(989	)		(6,192	)
Total assets (3)		578,158			27,195			239,533			95,131			940,017
Long-lived assets (2)(3)		482,513			19,522			103,945			80,722			686,702
Three months ended September 30, 2015
Revenues	$	128,768		$	9,614		$	46,915		$	20,736		$	206,033
Segment profit		22,242			1,274			8,839			4,721			37,076
Depreciation and amortization expense		8,519			61			2,128			2,289			12,997
Capital expenditures		(1,746	)		(39	)		(232	)		(478	)		(2,495	)

Nine months ended September 30, 2015
Revenues	$	382,611		$	27,235		$	140,371		$	60,870		$	611,087
Segment profit		64,516			3,257			24,020			13,591			105,384
Depreciation and amortization expense		27,001			751			6,608			7,214			41,574
Capital expenditures		(5,067	)		(208	)		(667	)		(1,395	)		(7,337	)
Total assets (3)		720,864			24,223			247,067			76,267			1,068,421
Long-lived assets (2)(3)		464,505			14,802			93,854			59,629			632,790

(1) For segment purposes, the Company defines “segment profit” as earnings before interest expenses, income taxes, depreciation and amortization, share-based compensation expenses, acquisition related transaction costs and other expenses. A consolidated reconciliation from segment profit to income from operations is included below.

(2) Long-lived assets are noncurrent assets excluding deferred tax assets and deferred financing costs.

(3) Total assets and long-lived assets include goodwill. Goodwill recorded in connection with certain tax benefits to be realized in the Company’s U.S. income tax returns has been reflected in the United States segment.

A reconciliation of segment profit to consolidated income from operations is as follows (in thousands):

	For the three months ended September 30,						For the nine months ended September 30,
	2014			2015			2014			2015
Segment Profit	$	36,083		$	37,075		$	98,672		$	105,384
Depreciation and amortization		(15,705	)		(12,997	)		(44,905	)		(41,574	)
Share-based compensation expense		(4,680	)		(5,393	)		(14,660	)		(18,094	)
Acquisition related transaction costs		(871	)		(634	)		(2,825	)		(1,327	)
Other income (expenses)		(585	)		84			(771	)		749
Income from operations	$	14,242		$	18,135		$	35,511		$	45,138

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(14)

Condensed Consolidating Financial Information of Guarantor Subsidiaries

The Company has outstanding certain indebtedness that is guaranteed by all of its U.S. subsidiaries. However, the indebtedness is not guaranteed by the Company’s foreign subsidiaries. The guarantor subsidiaries are 100% owned and the guarantees are made on a joint and several basis, and are full and unconditional. Separate consolidated financial statements of the guarantor subsidiaries have not been presented because management believes that such information would not be material to investors. However, condensed consolidating financial information as of December 31, 2014 and September 30, 2015, and for the three and nine months ended September 30, 2014 and 2015 is presented below. The Company (issuer of the Senior Unsecured Notes) was formed in September 2010 to implement a holding company organizational structure. As a result, all operating activities are conducted through the Company’s 100% owned subsidiaries.

Condensed Consolidating Statement of Operations

for the three months ended September 30, 2014

(In thousands)

	Guarantor Subsidiaries		Non-Guarantor Subsidiaries		ExamWorks Group, Inc. (Parent Corporation)		Consolidation and Elimination Entries			Consolidated Totals

Revenues	$	123,112	$	80,966	$	—	$	—		$	204,078
Costs and expenses:
Costs of revenues		80,796		49,801		—		—			130,597
Selling, general and administrative expenses		22,970		20,564		—		—			43,534
Depreciation and amortization		9,149		6,556		—		—			15,705
Total costs and expenses		112,915		76,921		—		—			189,836
Income from operations		10,197		4,045		—		—			14,242
Interest and other expenses, net		6,346		2,009		—		—			8,355
Income before income taxes		3,851		2,036		—		—			5,887
Provision for income taxes		1,024		1,448		—		—			2,472
Net income before earnings of consolidated subsidiaries	$	2,827	$	588	$	—	$	—		$	3,415
Net income (loss) of consolidated subsidiaries		588		—		588		(1,176	)		—
Net income (loss)	$	3,415	$	588	$	588	$	(1,176	)	$	3,415

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

Condensed Consolidating Statement of Operations

for the nine months ended September 30, 2014

(In thousands)

	Guarantor Subsidiaries			Non- Guarantor Subsidiaries			ExamWorks Group, Inc. (Parent Corporation)			Consolidation and Elimination Entries		Consolidated Totals

Revenues	$	346,504		$	227,047		$	—		$	—	$	573,551
Costs and expenses:
Costs of revenues		228,346			138,137			—			—		366,483
Selling, general and administrative expenses		66,521			60,131			—			—		126,652
Depreciation and amortization		25,037			19,868			—			—		44,905
Total costs and expenses		319,904			218,136			—			—		538,040
Income from operations		26,600			8,911			—			—		35,511
Interest and other expenses, net		18,154			5,873			—			—		24,027
Income before income taxes		8,446			3,038			—			—		11,484
Provision for income taxes		498			4,328			—			—		4,826
Net income (loss) before earnings of consolidated subsidiaries	$	7,948		$	(1,290	)	$	—		$	—	$	6,658
Net income (loss) of consolidated subsidiaries		(1,290	)		—			(1,290	)		2,580		—
Net income (loss)	$	6,658		$	(1,290	)	$	(1,290	)	$	2,580	$	6,658

Condensed Consolidating Statement of Operations

for the three months ended September 30, 2015

(In thousands)

	Guarantor Subsidiaries		Non- Guarantor Subsidiaries		ExamWorks Group, Inc. (Parent Corporation)		Consolidation and Elimination Entries			Consolidated Totals

Revenues	$	128,768	$	77,265	$	—	$	—		$	206,033
Costs and expenses:
Costs of revenues		86,779		47,667		—		—			134,446
Selling, general and administrative expenses		21,904		18,551		—		—			40,455
Depreciation and amortization		8,519		4,478		—		—			12,997
Total costs and expenses		117,202		70,696		—		—			187,898
Income from operations		11,566		6,569		—		—			18,135
Interest and other expenses, net		6,579		1,421		—		—			8,000
Income before income taxes		4,987		5,148		—		—			10,135
Provision for income taxes		970		2,010		—		—			2,980
Net income before earnings of consolidated subsidiaries	$	4,017	$	3,138	$	—	$	—		$	7,155
Net income (loss) of consolidated subsidiaries		3,138		—		3,138		(6,276	)		—
Net income (loss)	$	7,155	$	3,138	$	3,138	$	(6,276	)	$	7,155

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

Condensed Consolidating Statement of Operations

for the nine months ended September 30, 2015

(In thousands)

	Guarantor Subsidiaries			Non- Guarantor Subsidiaries		ExamWorks Group, Inc. (Parent Corporation)		Consolidation and Elimination Entries			Consolidated Totals

Revenues	$	382,611		$	228,476	$	—	$	—		$	611,087
Costs and expenses:
Costs of revenues		257,735			141,312		—		—			399,047
Selling, general and administrative expenses		68,607			56,721		—		—			125,328
Depreciation and amortization		27,001			14,573		—		—			41,574
Total costs and expenses		353,343			212,606		—		—			565,949
Income from operations		29,268			15,870		—		—			45,138
Interest and other expenses, net		40,001			4,570		—		—			44,571
Income (loss) before income taxes		(10,733	)		11,300		—		—			567
Provision (benefit) for income taxes		(6,621	)		5,872		—		—			(749	)
Net income (loss) before earnings of consolidated subsidiaries	$	(4,112	)	$	5,428	$	—	$	—		$	1,316
Net income (loss) of consolidated subsidiaries		5,428			—		5,428		(10,856	)		—
Net income (loss)	$	1,316		$	5,428	$	5,428	$	(10,856	)	$	1,316

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

Condensed Consolidating Balance Sheet as of December 31, 2014

(In thousands)

	Guarantor Subsidiaries		Non-Guarantor Subsidiaries		ExamWorks Group, Inc. (Parent Corporation)		Consolidation and Elimination Entries			Consolidated Totals
Assets
Current assets:
Cash and cash equivalents	$	388	$	9,363	$	—	$	—		$	9,751
Accounts receivable, net		55,684		147,505		—		—			203,189
Intercompany receivable		42,002		—		10,667		(52,669	)		—
Prepaid expenses		8,248		5,557		—		—			13,805
Deferred tax assets		3,780		—		—		(4	)		3,776
Other current assets		272		1,165		—		—			1,437
Total current assets		110,374		163,590		10,667		(52,673	)		231,958
Property, equipment and leasehold improvements, net		10,394		5,332		—		—			15,726
Investment in subsidiaries		217,344		—		591,435		(808,779	)		—
Intercompany notes receivable		174,464		—		174,464		(348,928	)		—
Goodwill		387,104		108,575		—		—			495,679
Intangible assets, net		64,530		38,053		—		—			102,583
Long-term accounts receivable, less current portion		—		46,401		—		—			46,401
Deferred tax assets, noncurrent		22,505		7,177		—		—			29,682
Deferred financing costs, net		6,140		29		—		—			6,169
Other assets		663		1,283		—		—			1,946
Total assets	$	993,518	$	370,440	$	776,566	$	(1,210,380	)	$	930,144
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Accounts payable	$	20,163	$	36,870	$	—	$	—		$	57,033
Intercompany payable		10,667		42,002		—		(52,669	)		—
Accrued expenses		23,904		30,074		—		—			53,978
Accrued interest expense		—		—		10,667		—			10,667
Deferred revenue		244		6,158		—		—			6,402
Deferred tax liability		—		4		—		(4	)		—
Current portion of contingent earnout obligation		—		4,473		—		—			4,473
Current portion of working capital facilities		—		40,396		—		—			40,396
Other current liabilities		2,363		4,587		—		—			6,950
Total current liabilities		57,341		164,564		10,667		(52,673	)		179,899
Senior unsecured notes payable		—		—		250,000		—			250,000
Senior secured revolving credit facility and working capital facilities, less current portion		—		—		143,853		—			143,853
Intercompany notes payable		174,464		174,464		—		(348,928	)		—
Long-term contingent earnout obligation, less current portion		—		2,114		—		—			2,114
Other long-term liabilities		1,795		7,608		—		—			9,403
Total liabilities		233,600		348,750		404,520		(401,601	)		585,269
Commitments and contingencies
Stockholders’ equity (deficit)		759,918		21,690		372,046		(808,779	)		344,875
Total liabilities and stockholders' equity (deficit)	$	993,518	$	370,440	$	776,566	$	(1,210,380	)	$	930,144

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

Condensed Consolidating Balance Sheet as of September 30, 2015

(In thousands)

	Guarantor Subsidiaries		Non-Guarantor Subsidiaries		ExamWorks Group, Inc. (Parent Corporation)		Consolidation and Elimination Entries			Consolidated Totals
Assets
Current assets:
Cash and cash equivalents	$	115,222	$	12,116	$	—	$	—		$	127,338
Accounts receivable, net		64,657		160,852		—		—			225,509
Intercompany receivable		53,593		—		12,892		(66,485	)		—
Prepaid expenses		10,478		4,422		—		—			14,900
Deferred tax assets		4,976		96		—		—			5,072
Other current assets		2,351		1,137		—		—			3,488
Total current assets		251,277		178,623		12,892		(66,485	)		376,307
Property, equipment and leasehold improvements, net		11,979		5,099		—		—			17,078
Investment in subsidiaries		222,773		—		731,849		(954,622	)		—
Intercompany notes receivable		174,375		—		174,375		(348,750	)		—
Goodwill		392,636		96,896		—		—			489,532
Intangible assets, net		49,778		21,718		—		—			71,496
Long-term accounts receivable, less current portion		—		52,497		—		—			52,497
Deferred tax assets, noncurrent		43,727		5,931		—		—			49,658
Deferred financing costs, net		9,635		118		—		—			9,753
Other assets		711		1,389		—		—			2,100
Total assets	$	1,156,891	$	362,271	$	919,116	$	(1,369,857	)	$	1,068,421
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Accounts payable	$	23,552	$	35,688	$	—	$	—		$	59,240
Intercompany payable		12,892		53,593		—		(66,485	)		—
Accrued expenses		18,717		35,557		—		—			54,274
Accrued interest expense		—		—		12,892		—			12,892
Deferred revenue		162		3,996		—		—			4,158
Other current liabilities		2,173		3,668		—		—			5,841
Total current liabilities		57,496		132,502		12,892		(66,485	)		136,405
Senior unsecured notes payable		—		—		500,000		—			500,000
Senior secured revolving credit facility and working capital facilities		—		38,838		—		—			38,838
Intercompany notes payable		174,375		174,375		—		(348,750	)		—
Deferred tax liability, noncurrent		5,587		—		—		—			5,587
Other long-term liabilities		3,701		9,026		—		—			12,727
Total liabilities		241,159		354,741		512,892		(415,235	)		693,557
Commitments and contingencies
Stockholders’ equity (deficit)		915,732		7,530		406,224		(954,622	)		374,864
Total liabilities and stockholders' equity (deficit)	$	1,156,891	$	362,271	$	919,116	$	(1,369,857	)	$	1,068,421

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2014

(In thousands)

	Guarantor Subsidiaries			Non-Guarantor Subsidiaries			ExamWorks Group, Inc. (Parent Corporation)			Consolidation and Elimination Entries		Consolidated Totals

Net cash provided by operating activities	$	18,266		$	6,695		$	—		$	—	$	24,961
Investing activities:
Cash paid for acquisitions, net		(177,864	)		(9,538	)		—			—		(187,402	)
Purchases of equipment and leasehold improvements, net		(4,171	)		(2,021	)		—			—		(6,192	)
Working capital and other settlements for acquisitions		(497	)		(1,869	)		—			—		(2,366	)
Cash paid for foreign currency net investment hedge		(362	)		—			—			—		(362	)
Other		(939	)		—			—			—		(939	)
Net cash used in investing activities		(183,833	)		(13,428	)		—			—		(197,261	)
Financing activities:
Borrowings under senior secured revolving credit facility		—			—			269,621			—		269,621
Proceeds from the exercise of options and warrants					—			35,394			—		35,394
Excess tax benefit related to share-based compensation					—			12,700			—		12,700
Net borrowings under working capital facilities					7,506			—			—		7,506
Payment of deferred financing costs					—			(251	)		—		(251	)
Repayment of subordinated unsecured notes payable		(333	)		—			—			—		(333	)
Payment of contingent earnout obligation		—			(4,362	)		—			—		(4,362	)
Repayment under senior secured revolving credit facility		—			—			(151,290	)		—		(151,290	)
Intercompany notes and investments and other		166,121			—			(166,174	)		—		(53	)
Net cash provided by financing activities		165,788			3,144			—			—		168,932
Exchange rate impact on cash and cash equivalents		—			(350	)		—			—		(350	)
Net increase (decrease) in cash and cash equivalents		221			(3,939	)		—			—		(3,718	)
Cash and cash equivalents, beginning of period		760			12,069			—			—		12,829
Cash and cash equivalents, end of period	$	981		$	8,130		$	—		$	—	$	9,111

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2015

(In thousands)

	Guarantor Subsidiaries			Non-Guarantor Subsidiaries			ExamWorks Group, Inc. (Parent Corporation)			Consolidation and Elimination Entries		Consolidated Totals

Net cash provided by operating activities	$	28,717		$	12,911		$	—		$	—	$	41,628
Investing activities:
Cash paid for acquisitions, net		(11,145	)		(625	)		—			—		(11,770	)
Purchases of equipment and leasehold improvements, net		(5,068	)		(2,269	)		—			—		(7,337	)
Working capital and other settlements for acquisitions		(181	)		—			—			—		(181	)
Cash proceeds from foreign currency net investment hedge		4,122			—			—			—		4,122
Other		(1,427	)		—			—			—		(1,427	)
Net cash used in investing activities		(13,699	)		(2,894	)		—			—		(16,593	)
Financing activities:
Borrowings under senior unsecured notes		—			—			500,000			—		500,000
Borrowings under senior secured revolving credit facility		—			—			25,478			—		25,478
Proceeds from the exercise of options and warrants		—			—			13,737			—		13,737
Excess tax benefit related to share-based compensation		—			—			3,111			—		3,111
Net borrowings under working capital facilities		—			(607	)		—			—		(607	)
Repayment of contingent earnout obligation		—			(5,064	)		—			—		(5,064	)
Payment of deferred financing costs		—			(144	)		(8,562	)		—		(8,706	)
Payment for early redemption of senior unsecured notes		—			—			(14,618	)		—		(14,618	)
Repayment under senior secured revolving credit facility		—			—			(169,331	)		—		(169,331	)
Repayments under senior unsecured notes		—			—			(250,000	)		—		(250,000	)
Intercompany notes and investments and other		99,815			—			(99,815	)		—		—
Net cash provided by (used in) financing activities		99,815			(5,815	)		—			—		94,030
Exchange rate impact on cash and cash equivalents		—			(1,448	)		—			—		(1,448	)
Net increase in cash and cash equivalents		114,833			2,754			—			—		117,587
Cash and cash equivalents, beginning of period		388			9,363			—			—		9,751
Cash and cash equivalents, end of period	$	115,221		$	12,117		$	—		$	—	$	127,338

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(15)	Subsequent Events

Acquisitions

On October 30, 2015 the Company completed the asset acquisition of F.C.M.E. Management, Inc. and Independent Diagnostics Testing, Inc (collectively “First Choice”) an IME provider based in Buffalo, NY, with annual revenues of approximately $24.0 million, strengthening its market position in the IME Industry.

Share Repurchase

On November 3, 2015 the Board of Directors approved an increase to the previously authorized share repurchase program. The Company is now authorized to repurchase up to $75.0 million of outstanding shares of the Company's common stock, of which approximately $65.0 million is currently available.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-looking Statements

Unless the context indicates otherwise, references in this Quarterly Report on Form 10-Q to “ExamWorks,” “the Company,” “we,” “our,” and “us” mean ExamWorks Group, Inc. and its consolidated subsidiaries.

The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and the related notes and the other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties. Forward-looking statements convey current expectations or forecasts of future events for ExamWorks. All statements contained in this report other than statements of historical fact, including statements regarding our future results of operations and financial position, business strategy and plans, and our objectives for future operations, are forward-looking. You can identify forward-looking statements by terminology such as “project,” “believe,” “anticipate,” “plan,” “expect,” “estimate,” “intend,” “should,” “would,” “could,” “will,” “can,” “continue,” or “may,” or the negative of these terms or other similar expressions that convey uncertainty of future events or outcomes. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section titled “Risk Factors,” set forth in Part II, Item 1A. of this Quarterly Report on Form 10-Q and elsewhere in this report, and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. The forward-looking statements in this Quarterly Report on Form 10-Q represent our views as of the date of this report. Subsequent events and developments may cause our views to change. While we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this report.

Our Business

We are a leading provider of independent medical examinations (“IMEs”), peer and bill reviews, Medicare compliance services, case management services and other related services, which include legal support services, administrative support services and medical record retrieval services. We were incorporated as a Delaware corporation on April 27, 2007. From July 14, 2008 through the date of this filing, we have acquired 53 IME services businesses, including a leading provider of software solutions to the IME industry. We currently operate out of 67 service centers servicing all 50 U.S. states, Canada, the United Kingdom and Australia. We conduct our business through four geographic segments: the United States, Canada, the United Kingdom and Australia.

We provide our services to property and casualty insurance carriers, law firms, third-party claim administrators, government agencies, and state funds that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate the delivery and quality of cost-effective care for workers’ compensation, automotive, personal injury liability and disability insurance coverage. We help our clients manage costs and enhance their risk management processes by verifying the validity, nature, cause and extent of claims, identifying fraud and providing fast, efficient and quality IME services.

We provide our clients with the local presence, expertise and broad geographic coverage they increasingly require. Our size and geographic reach give our clients access to our medical panel of credentialed physicians and other medical providers and our proprietary information technology infrastructure that has been specifically designed to streamline the complex process of coordinating referrals, scheduling appointments, complying with regulations and client reporting. Our primary service is to provide IMEs that give our clients authoritative and accurate answers to questions regarding the nature and permanency of medical conditions or personal injury, their cause and appropriate treatment. Additionally, we provide peer and bill reviews, which consist of medical opinions by members of our medical panel without conducting physical exams, and the review of physician and hospital bills to examine medical care rendered and its conformity to accepted standards of care. Prior to our acquisition of MES Group, Inc. (“MES”) in February 2011, we marketed our services primarily under the ExamWorks brand. Initially with the MES acquisition and subsequently with the Premex Group Limited (“Premex”) and MedHealth Holdings Pty. Limited (“MedHealth”) acquisitions, we began to market our services under several brands, including but not limited to, ExamWorks, MES, Premex and MedHealth. Further, with the acquisition of Gould & Lamb in February 2014 and Ability Services Network and MedAllocators in June 2014, we expanded our presence in Medicare compliance services, including Medicare set-aside and reporting services, that help mitigate costs and promote compliance, and case management services, which include managing the medical and vocational cases of injured workers to facilitate timely recovery and/or return to work. These services are marketed under ExamWorks Clinical Solutions.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Significant Recent Developments

Acquisitions

A key feature of our strategy is to grow our business organically by selling additional services to existing clients, cross-selling into additional insurance lines of business and expanding our geographic footprint with existing clients. Because we operate in a highly fragmented industry, and have completed numerous acquisitions, another component of our business strategy has historically been and continues to be growth through acquisitions that expand our geographic coverage, provide new or complementary lines of business, expand our portfolio of services, and increase our market share. For example, our acquisition of MedHealth in August 2012 enabled us to enter the Australian market and expand our range of clients and services, and increase our international market presence. Similarly, our acquisitions of Gould & Lamb in February 2014 and Ability Services Network and MedAllocators in June 2014 enabled us to expand our presence in the Medicare compliance services and case management services markets and offer a wider range of services to new and existing clients. To date, we have completed 53 acquisitions and below we include the acquisitions completed in 2014 and 2015:

Acquisition Date	Name
October 30, 2015	•	First Choice
July 13, 2015	•	Karen Rucas & Associates
April 14, 2015	•	Landmark Exams & Maven Exams
January 2, 2015	•	ReliableRS
August 22, 2014	•	Expert Medical Opinions
June 6, 2014	•	Ability Services Network and MedAllocators
May 30, 2014	•	Solomon Associates
February 14, 2014	•	Assess Medical
February 3, 2014	•	Gould & Lamb
January 16, 2014	•	Newton Medical Group
January 13, 2014	•	Cheselden

Sources of Revenues and Expenses

Revenues

We derive revenue primarily from fees charged for independent medical examinations, peer and bill reviews, Medicare compliance services, case management services and other related services, which include litigation support services, administrative support services and medical record retrieval services. Revenues are recognized at the time services have been performed and, if applicable, at the time the report is shipped to the end user. We expect revenue to continue to increase through acquisition and organic growth. Our revenue is derived from services performed in different geographic areas.

Certain agreements with customers in the U.K. include provisions whereby collection of the amounts billed are contingent on the favorable outcome of the claim. We have deemed these provisions to preclude revenue recognition at the time of performance, as collectability is not reasonably assured and the cash payments are contingent, and are deferring these revenues, net of estimated costs, until the case has been settled and the contingency has been resolved and the cash has been collected.

Costs of revenues

Costs of revenues are comprised of fees paid to members of our medical panel; other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenue. We expect these operationally driven costs to increase to support future revenue growth and as we continue to grow through acquisitions.

Selling, general and administrative expenses

Selling, general and administrative (“SGA”) expenses consist primarily of expenses for administrative, human resource related, corporate information technology support, legal (primarily from transaction costs related to acquisitions), finance and accounting personnel, professional fees (primarily from transaction costs related to acquisitions), insurance and other corporate expenses. We expect that SGA expenses will increase as we continue to add personnel to support the growth of our business and pursue acquisition growth. In addition, we may incur additional personnel expenses, professional service fees, including audit and legal, investor relations, costs of compliance with securities laws and regulations, and higher director and officer insurance costs related to operating as a public company. As a result, we expect that our SGA expenses will continue to increase in the future but decrease as a percentage of revenue over time as our revenue increases.

Depreciation and amortization

Depreciation and amortization (“D&A”) expense consists primarily of amortization of our finite lived intangible assets obtained through acquisitions completed to date and, to a lesser extent, depreciation of property, equipment and leasehold improvements. We expect that depreciation and amortization expense will decrease as a percentage of revenues as our finite lived intangible assets become fully amortized.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Results of Operations

As stated previously, our revenues consist primarily of fees charged for IME services performed. What we are able to charge per IME service performed depends on many factors relating to the type of IME services that our clients request. Those factors include, among others, (1) the line of business (e.g., worker’s compensation, automotive or liability claim), (2) product group (e.g., IME or peer review), (3) the geographic location of the claimant and (4) the medical panel provider we are able to use and his or her specialty. These factors impact the revenue generated by each IME service request differently and are largely out of our control. As a result, our management team focuses its efforts on increasing the volume of IME service requests received and completed and not necessarily their type. Changes in revenue that we cannot attribute to increases or decreases in volume we attribute to changes in sales mix. Our largest cost is payments made to members of our medical panel. For the majority of our revenues, these costs are variable, as most of the medical panel members are independent contractors, allowing us to maintain and manage our costs of revenues more effectively. The following table sets forth our consolidated statements of operations data for each of the periods indicated (in thousands, except per share data):

	For the three months ended September 30,				For the nine months ended September 30,
	2014		2015		2014		2015
Revenues	$	204,078	$	206,033	$	573,551	$	611,087
Costs and expenses:
Costs of revenues		130,597		134,446		366,483		399,047
Selling, general and administrative expenses		43,534		40,455		126,652		125,328
Depreciation and amortization		15,705		12,997		44,905		41,574
Total costs and expenses		189,836		187,898		538,040		565,949
Income from operations		14,242		18,135		35,511		45,138
Interest and other expenses, net		8,355		8,000		24,027		44,571
Income before income taxes		5,887		10,135		11,484		567
Provision (benefit) for income taxes		2,472		2,980		4,826		(749	)
Net income	$	3,415	$	7,155	$	6,658	$	1,316

Per share data
Net income per share
Basic	$	0.09	$	0.17	$	0.17	$	0.03
Diluted	$	0.08	$	0.17	$	0.16	$	0.03

Weighted average number of common shares outstanding
Basic		39,251		41,384		38,259		40,936
Diluted		41,647		43,158		40,897		42,981

Other Financial Data:
Adjusted EBITDA(1)	$	36,083	$	37,075	$	98,672	$	105,384

(1)	Adjusted EBITDA is a non-GAAP measure that is described and reconciled to net income in the next section and is not a substitute for the GAAP equivalent.

Adjusted EBITDA

In connection with the ongoing operation of our business, our management regularly reviews Adjusted EBITDA, a non-GAAP financial measure, to assess our performance. We define Adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, acquisition-related transaction costs, share-based compensation expenses, and other expenses. We believe that Adjusted EBITDA is an important measure of our operating performance because it allows management, lenders, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of changes to our capitalization structure, acquisition related costs, income tax status, and other items of a non-operational nature that affect comparability.

We believe that various forms of the Adjusted EBITDA metric are often used by analysts, investors and other interested parties to evaluate companies such as ours for the reasons discussed above. Additionally, Adjusted EBITDA is used to measure certain financial covenants in our credit facility. Adjusted EBITDA is also used for planning purposes and in presentations to our Board of Directors as well as in our incentive compensation programs for our employees.

Non-GAAP information should not be construed as an alternative to GAAP information, as the items excluded from the non-GAAP measures often have a material impact on our financial results. Management uses, and investors should use, non-GAAP measures in conjunction with our GAAP results.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

The following table presents a reconciliation to Adjusted EBITDA from net income, the most comparable GAAP measure, for each of the periods indicated (in thousands):

	For the three months ended September 30,					For the nine months ended September 30,
	2014		2015			2014		2015
Net income	$	3,415	$	7,155		$	6,658	$	1,316
Share-based compensation expense (1)		4,680		5,393			14,660		18,094
Depreciation and amortization		15,705		12,997			44,905		41,574
Acquisition-related transaction costs		871		634			2,825		1,327
Other (income) expenses (2)		585		(84	)		771		(749	)
Interest and other expenses, net		8,355		8,000			24,027		44,571
Provision (benefit) for income taxes		2,472		2,980			4,826		(749	)
Adjusted EBITDA		36,083		37,075			98,672		105,384

(1)

Share-based compensation expense of $444,000 and $1.6 million is included in costs of revenues for the three and nine months ended September 30, 2014, respectively, and the remainder is included in SGA expenses. Share-based compensation expense of $259,000 and $987,000 million is included in costs of revenues for the three and nine months ended September 30, 2015, respectively, and the remainder is included in SGA expenses.

(2)	Other expenses consist principally of integration related expenses, such as facility termination, severance and relocation costs and gains or losses on earnout settlements associated with our acquisition strategy.

Comparison of the Three Months Ended September 30, 2015 and 2014

Revenues. Revenues were $206.0 million for the three months ended September 30, 2015 compared to $204.1 million for the three months ended September 30, 2014, an increase of $2.0 million, or 1%. Of the increase in revenues compared to 2014, $3.0 million, or 1.5%, was attributable to acquisitions completed in 2014 and 2015 offset by a decrease of $1.0 million, or 0.5%, due primarily to the negative impact of foreign currency on our existing businesses.

●

U.S. segment revenues were $128.8 million for the three months ended September 30, 2015 compared to $123.1 million for the three months ended September 30, 2014, an increase of $5.7 million, or 5%. Of the increase in U.S. revenues compared to 2014, $2.8 million, or 2.3%, was attributable to acquisitions completed in 2014 and 2015 and $2.9 million, or 2.3%, was due to growth in our existing businesses, of which approximately 65% related to increases in our IME and related services product group. The growth in the existing businesses was due to an approximate 4% increase in service volumes, offset by an unfavorable change in sales mix.

●

Canada segment revenues were $9.6 million for the three months ended September 30, 2015 compared to $8.1 million for the three months ended September 30, 2014, an increase of $1.5 million or 19%. Excluding the impact of currency, the existing Canada businesses grew 40.4%. The constant currency growth in Canada revenues compared to 2014 was due primarily to a favorable change in sales mix, and to a lesser extent, increases in IME service volumes.

●

U.K. segment revenues were $46.9 million for the three months ended September 30, 2015 compared to $48.9 million for the three months ended September 30, 2014, a decrease of $2.0 million, or 4%. Excluding the impact of currency, the existing U.K. businesses grew 3.6%. The constant currency growth in the existing businesses was due to increased IME service volumes, offset by an unfavorable change in sales mix.

●

Australia segment revenues were $20.7 million for the three months ended September 30, 2015 compared to $24.0 million for the three months ended September 30, 2014, a decrease of $3.3 million, or 14%. Excluding the impact of currency, the existing Australian businesses grew 10.0%. The constant currency growth in the existing business was primarily due to increased a favorable change in sales mix, and to a lesser extent, increased IME service volumes.

Costs of revenues. Costs of revenues were $134.4 million for the three months ended September 30, 2015 compared to $130.6 million for the three months ended September 30, 2014, an increase of $3.8 million, or 3%. Of the increase in costs of revenues compared to 2014, $2.1 million, or 1.6%, was attributable to acquisitions completed in 2014 and 2015 and $1.7 million, or 1.3%, was related to our existing businesses primarily attributable to increased fees paid to members of our medical panel and, to a lesser extent, an increase in other direct costs. Costs of revenues as a percentage of revenues was 65.3% for the three months ended September 30, 2015, a 1.3% increase from the 64.0% for the three months ended September 30, 2014. The increase was due to a change in sales mix and a legislative impact on our U.K. business.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Selling, general and administrative. SGA expenses were $40.5 million for the three months ended September 30, 2015 compared to $43.5 million for the three months ended September 30, 2014, a decrease of $3.1 million, or 7%. Of the decrease in SGA expenses compared to 2014, $3.5 million, or 8%, was attributable to improvements in our existing businesses, offset by an increase of $412,000, or 1%, attributable acquisitions completed in 2014 and 2015. The improvements were primarily attributable to reductions in referral commissions in our U.K. business of approximately $1.6 million, reduced personnel expenses of approximately $1.0 million and $585,000 in reduced travel and acquisition related transaction costs.

Depreciation and amortization. D&A expenses were $13.0 million for the three months ended September 30, 2015 compared to $15.7 million for the three months ended September 30, 2014, a decrease of $2.7 million, or 17%. Of the decrease in D&A expenses compared to 2014, $3.2 million, or 20%, was attributable to our existing businesses as historic finite-lived intangible and tangible assets became fully amortized, offset by an increase due to acquisitions completed in 2014 and 2015.

Interest and other expenses, net. Interest and other expenses, net, were $8.0 million for the three months ended September 30, 2015 compared to $8.4 million for the three months ended September 30, 2014, a decrease of $355,000, or 4%. Interest and other expenses, net, decreased primarily due to the change in our debt profile from the comparable period of the 2014 year.

Provision for income taxes. Provision for income taxes was $3.0 million for the three months ended September 30, 2015 compared to $2.5 million for the three months ended September 30, 2014, an increase of $508,000, or 21%. Our effective income tax rate was 29.4% and 42.0% for the three months ended September 30, 2015 and 2014, respectively. The tax rates in the 2015 and 2014 periods were impacted primarily by elections made for certain foreign acquisitions, foreign rate differentials and non-deductible items.

Net income. For the foregoing reasons, net income was $7.2 million for the three months ended September 30, 2015 compared to net income of $3.4 million for the three months ended September 30, 2014.

Adjusted EBITDA. Adjusted EBITDA was $37.1 million for the three months ended September 30, 2015 compared to $36.1 million for the three months ended September 30, 2014, an increase of $1.0 million, or 3%. The increase in Adjusted EBITDA was primarily due to the 1% increase in revenues. Adjusted EBITDA is also described as Segment Profit elsewhere in this Report (See Note 13 within Notes to Consolidated Financial Statements).

●

U.S. segment Adjusted EBITDA was $22.2 million for the three months ended September 30, 2015 compared to $21.2 million for the three months ended September 30, 2014, an increase of $1.1 million, or 5%. The increase in Adjusted EBITDA was due to the 5% increase in U.S. segment revenues, offset by a 4% increase in costs of revenues and SGA expenses primarily due to increased fees paid to members of our medical panel as these costs are variable in nature and increased personnel expense to support the growth in our business, excluding share-based compensation.

●

Canada segment Adjusted EBITDA was $1.3 million for the three months ended September 30, 2015 compared to $842,000 for the three months ended September 30, 2014, an increase of $432,000, or 51%. On a constant currency basis, Canada segment Adjusted EBITDA increased 82%. The constant currency increase in Adjusted EBITDA was due to the 43% increase in Canada segment revenues and a 38% increase in costs of revenues and SGA expenses primarily due to increased fees paid to members of our medical panel as these costs are variable in nature.

●

U.K. segment Adjusted EBITDA was $8.8 million for the three months ended September 30, 2015 compared to $8.2 million for the three months ended September 30, 2014, an increase of $685,000, or 8%. On a constant currency basis, U.K. segment Adjusted EBITDA increased 17%. The constant currency increase in Adjusted EBITDA was due to the 4% increase in U.K. segment revenues and a 1% increase in costs of revenues and SGA expenses primarily due to decreased fees paid to members of our medical panel as these costs are variable in nature. Adjusted EBITDA was also negatively impacted by a legislative change in the U.K., which impacted revenues and Adjusted EBITDA.

●

Australia segment Adjusted EBITDA was $4.7 million for the three months ended September 30, 2015 compared to $5.9 million for the three months ended September 30, 2014, a decrease of $1.2 million, or 20%. On a constant currency basis, Australia segment Adjusted EBITDA increased 2%. The constant currency increase in Adjusted EBITDA was due to the 10% increase in Australia segment revenues and a 13% increase in costs of revenues and SGA expenses primarily due to increased fees paid to members of our medical panel as a percentage of revenues as these costs are variable in nature and increased personnel expenses.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Comparison of the Nine months Ended September 30, 2015 and 2014

Revenues. Revenues were $611.1 million for the nine months ended September 30, 2015 compared to $573.6 million for the nine months ended September 30, 2014, an increase of $37.5 million, or 7%. Of the increase in revenues compared to 2014, $24.2 million, or 4.2%, was attributable to acquisitions completed in 2014 and 2015 and $13.3 million, or 2.3%, was due to growth in our existing businesses.

●

U.S. segment revenues were $382.6 million for the nine months ended September 30, 2015 compared to $346.5 million for the nine months ended September 30, 2014, an increase of $36.1 million, or 10%. Of the increase in U.S. revenues compared to 2014, $22.4 million, or 6%, was attributable to acquisitions completed in 2014 and 2015 and $13.8 million, or 4%, was due to growth in our existing businesses, of which approximately 50% related to increases in our IME and related services product group. The growth in the existing businesses was due to an approximate 8% increase in service volumes offset by an unfavorable change in sales mix.

●

Canada segment revenues were $27.2 million for the nine months ended September 30, 2015 compared to $24.2 million for the nine months ended September 30, 2014, an increase of $3.1 million or 13%. Excluding the impact of currency, the existing Canada businesses grew 29%. The constant currency growth in Canada revenues compared to 2014 was due primarily to a favorable change in sales mix, and to a lesser extent, increases in IME service volumes.

●

U.K. segment revenues were $140.4 million for the nine months ended September 30, 2015 compared to $139.6 million for the nine months ended September 30, 2014, an increase of $788,000 or 0.6%. Excluding the impact of currency, the existing U.K. businesses grew 10%. The constant currency growth in the existing businesses was due to increased IME service volumes, offset by an unfavorable change in sales mix. Revenues in our U.K. business were also negatively impacted in the nine months ended September 30, 2015 due to a legislative change that went into effect late in the fourth quarter of 2014.

●

Australia segment revenues were $60.9 million for the nine months ended September 30, 2015 compared to $63.3 million for the nine months ended September 30, 2014, a decrease of $2.4 million, or 4%. Excluding the impact of currency, the existing Australian businesses grew 13%. The constant currency growth in the existing business was primarily due to a favorable change in sales mix, and to a lesser extent, increased IME service volumes.

Costs of revenues. Costs of revenues were $399.0 million for the nine months ended September 30, 2015 compared to $366.5 million for the nine months ended September 30, 2014, an increase of $32.6 million, or 9%. Of the increase in costs of revenues compared to 2014, $18.9 million, or 5%, was attributable to acquisitions completed in 2014 and 2015 and $13.6 million, or 4%, was related to our existing businesses primarily attributable to increased fees paid to members of our medical panel and, to a lesser extent, an increase in other direct costs. Costs of revenues as a percentage of revenues was 65.3% for the nine months ended September 30, 2015, a 1.4% increase from the 63.9% for the nine months ended September 30, 2014. The increase was due to a change in sales mix and the legislative impact on our U.K. business.

Selling, general and administrative. SGA expenses were $125.3 million for the nine months ended September 30, 2015 compared to $126.7 million for the nine months ended September 30, 2014, a decrease of $1.3 million, or 1%. Of the decrease in SGA expenses compared to 2014, $6.3 million, or 5%, was related to our existing businesses, offset by an increase of $5.0 million, or 4% related acquisitions completed in 2014 and 2015. The improvements related to our existing business were primarily attributable to reductions in referral commissions in our U.K. business of approximately $3.6 million and $2.5 million in reduced acquisition related transaction costs.

Depreciation and amortization. D&A expenses were $41.6 million for the nine months ended September 30, 2015 compared to $44.9 million for the nine months ended September 30, 2014, a decrease of $3.3 million, or 7%. Of the decrease in D&A expenses compared to 2014, $7.7 million, or 17%, was attributable to our existing businesses as historic finite-lived intangible and tangible assets became fully amortized, offset by an increase due to acquisitions completed in 2014 and 2015.

Interest and other expenses, net. Interest and other expenses, net, were $44.6 million for the nine months ended September 30, 2015 compared to $24.0 million for the nine months ended September 30, 2014, an increase of $20.5 million, or 86%. Interest and other expenses, net, increased primarily due to fees associated with the early redemption of the Senior Unsecured Notes.

Provision (benefit) for income taxes. Benefit for income taxes was $749,000 for the nine months ended September 30, 2015 compared to a provision for income taxes of $4.8 million for the nine months ended September 30, 2014, an increased benefit of $5.6 million, or 116%. Our effective income tax rate was -132.1% and 42.0% for the nine months ended September 30, 2015 and 2014, respectively. The tax rates in the 2015 and 2014 periods were impacted primarily by elections made for certain foreign acquisitions, foreign rate differentials and non-deductible items.

Net income. For the foregoing reasons, net income was $1.3 million for the nine months ended September 30, 2015 compared to net income of $6.7 million for the nine months ended September 30, 2014.

Adjusted EBITDA. Adjusted EBITDA was $105.4 million for the nine months ended September 30, 2015 compared to $98.7 million for the nine months ended September 30, 2014, an increase of $6.7 million, or 7%. The increase in Adjusted EBITDA was primarily due to the 7% increase in revenues. Adjusted EBITDA is also described as Segment Profit elsewhere in this Report (See Note 13 within Notes to Consolidated Financial Statements).

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

●

U.S. segment Adjusted EBITDA was $64.5 million for the nine months ended September 30, 2015 compared to $57.8 million for the nine months ended September 30, 2014, an increase of $6.7 million, or 12%. The increase in Adjusted EBITDA was due to the 10% increase in U.S. segment revenues and a 10% increase in costs of revenues and SGA expenses primarily due to increased fees paid to members of our medical panel as these costs are variable in nature and increased personnel expense to support the growth in our business, excluding share-based compensation.

●

Canada segment Adjusted EBITDA was $3.3 million for the nine months ended September 30, 2015 compared to $3.1 million for the nine months ended September 30, 2014, an increase of $153,000, or 5%. On a constant currency basis, Canada segment Adjusted EBITDA increased 21%. The constant currency increase in Adjusted EBITDA was due to the 30% increase in Canada segment revenues and a 31% increase in costs of revenues and SGA expenses primarily due to increased fees paid to members of our medical panel as these costs are variable in nature.

●

U.K. segment Adjusted EBITDA was $24.0 million for the nine months ended September 30, 2015 compared to $23.6 million for the nine months ended September 30, 2014, an increase of $407,000, or 2%. On a constant currency basis, U.K. segment Adjusted EBITDA increased 11%. The constant currency increase in Adjusted EBITDA was due to the 10% increase in U.K. segment revenues and a 9% increase in costs of revenues and SGA expenses primarily due to increased fees paid to members of our medical panel as these costs are variable in nature. Adjusted EBITDA was also negatively impacted by a legislative change in the U.K., which impacted revenues and Adjusted EBITDA.

●

Australia segment Adjusted EBITDA was $13.6 million for the nine months ended September 30, 2015 compared to $14.2 million for the nine months ended September 30, 2014, a decrease of $593,000, or 4%. On a constant currency basis, Australia segment Adjusted EBITDA increased 16%. The constant currency increase in Adjusted EBITDA was due to the 16% increase in Australia segment revenues and a 16% increase in costs of revenues and SGA expenses primarily due to increased fees paid to members of our medical panel as these costs are variable in nature and increased personnel expenses.

Liquidity and Capital Resources

Our principal capital requirements are to fund operations and acquisitions. We fund our capital needs from cash flow generated from operations and borrowings under our Amended and Restated Credit Facility and working capital facilities. We have historically also funded our acquisition program with equity issuances to sellers. We expect that cash and cash equivalents, availability under our existing credit and working capital facilities, as amended and restated, and cash flow from operations will be sufficient to support our operations, planned capital expenditures and acquisitions for at least the next 12 months.

Although we believe that our current cash and cash equivalents following the issuance of the Notes, funds available under our Amended and Restated Credit Facility and working capital facilities will be sufficient to meet our working capital and acquisition plans for at least the next 12 months, we may need to raise additional funds through the issuance of equity or convertible debt securities or increase borrowings to fund acquisitions. If we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our existing stockholders will be reduced and these securities might have rights, preferences and privileges senior to those of our current stockholders. Additional financing may not be available or, if available, such financing may not be obtained on terms favorable to our stockholders and us.

Information related to our credit facilities, the Notes and cash flows as of September 30, 2015 follows below.

Credit Facilities

Credit Facility

On November 2, 2010, we entered into a senior secured revolving credit facility (the “Senior Secured Revolving Credit Facility”) with Bank of America, N.A. The facility initially consisted of a $180.0 million revolving credit facility. The facility was initially available to finance the Company’s acquisition program and working capital needs.

On April 16, 2015, we amended and restated the terms of our Senior Secured Revolving Credit Facility in connection with the offering of the Notes (See “Senior Unsecured Notes” below) pursuant to an amended and restated credit agreement (the “Amended and Restated Credit Facility”). The Amended and Restated Credit Facility provides for up to $300.0 million of revolving extensions of credit outstanding at any time (including revolving loans, swingline loans and letters of credit). During the term of the Amended and Restated Credit Facility, we have the right, subject to compliance with the covenants specified in the Amended and Restated Credit Facility and the Notes, to increase the revolving extensions under the Amended and Restated Credit Facility to a maximum of $400.0 million. The term of the Senior Secured Revolving Credit Facility was extended for five years from the date of the amendment to April 2020.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Borrowings under the Senior Secured Revolving Credit Facility, as amended, bear interest, at either (i) LIBOR plus the applicable margin or (ii) a base rate (equal to the highest of (a) the federal funds rate plus 0.5%, (b) the Bank of America prime rate and (c) LIBOR (using a one-month period) plus 1.0%), plus the applicable margin, as we elect. The applicable margin means a percentage per annum determined in accordance with the following table:

Pricing Tier	Consolidated Senior Secured Leverage Ratio			Commitment Fee/Unused Line Fee			Letter of Credit Fee			Eurocurrency Rate Loans			Base Rate Loans
1	≥ 4.00	to 1.0			0.45	%		2.75	%		2.75	%		1.75	%
2	≥ 3.50	to 1.0 but <	4.00 to 1.0		0.40	%		2.50	%		2.50	%		1.50	%
3	≥ 3.00	to 1.0 but <	3.50 to 1.0		0.35	%		2.25	%		2.25	%		1.25	%
4	≥ 2.50	to 1.0 but <	3.00 to 1.0		0.30	%		2.00	%		2.00	%		1.00	%
5		<	2.50 to 1.0		0.30	%		1.75	%		1.75	%		0.75	%

In the event of default, the outstanding indebtedness under the facility will bear interest at an additional 2%.

The Senior Secured Revolving Credit Facility contains restrictive covenants, including among other things financial covenants requiring us to not exceed a maximum consolidated senior secured leverage coverage ratio, a maximum total consolidated leverage ratio and to maintain a minimum consolidated fixed charge coverage ratio. The Senior Secured Revolving Credit Facility also restricts our ability (subject to certain exceptions) to incur indebtedness, prepay or amend other indebtedness, create liens, make certain fundamental changes including mergers or dissolutions, pay dividends and make other payments in respect of capital stock, make certain investments, sell assets, change its lines of business, enter into transactions with affiliates and other corporate actions.

On June 1, 2015, the Company entered into a first amendment to the Senior Secured Revolving Credit Facility (“First Amendment”). The First Amendment amended the definition of “Change of Control” in the Senior Secured Revolving Credit Facility.

As of September 30, 2015, we had no amount outstanding under the Senior Secured Revolving Credit Facility, resulting in $300.0 million of undrawn commitments.

Working Capital Facilities

On September 29, 2010, our indirect 100% owned subsidiary UK Independent Medical Services Limited (“UKIM”) entered into a Sales Finance Agreement (the “UKIM SFA”) with Barclays Bank PLC (“Barclays”), pursuant to which Barclays provides UKIM a working capital facility of up to £5,000,000, subject to the terms and conditions of the UKIM SFA. The working capital facility bore a discount margin of 2.5% over Base Rate and served to finance UKIM’s unpaid account receivables. The working capital facility had a minimum term of 36 months.

On May 12, 2011, Premex entered into a Sales Finance Agreement (the “Premex SFA”) with Barclays, pursuant to which Barclays provides Premex a working capital facility of up to £26,500,000, subject to the terms and conditions of the Premex SFA. The working capital facility bears a discount margin of 2.4% over Base Rate (0.5% rate on September 30, 2015) and serves to finance Premex’s unpaid account receivables. The working capital facility had a minimum term of 36 months.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Senior Unsecured Notes

In July 2011, we closed a private offering of $250.0 million in aggregate principal amount of 9.0% senior notes due 2019, which were subsequently registered through a public exchange offer (the “Senior Unsecured Notes”). The Senior Unsecured Notes were issued at a price of 100% of their principal amount. A portion of the gross proceeds of $250.0 million were used to repay borrowings outstanding under our Senior Secured Revolving Credit Facility and pay related fees and expenses, and the remainder was used for general corporate purposes, including acquisitions.

On April 16, 2015, we closed a public offering of $500.0 million in aggregate principal amount of 5.625% senior notes due 2023 (the “Notes”). The Notes were issued at a price of 100% of their principal amount. The Notes are our senior obligations and are guaranteed by certain of our existing and future U.S. subsidiaries. The gross proceeds of $500.0 million were used to repay all outstanding borrowings under the Senior Secured Revolving Credit Facility, to redeem all of the Senior Unsecured Notes, to pay related fees and expenses, and for general corporate purposes, including acquisitions.

The Notes were issued under an indenture, dated as of April 16, 2015, as supplemented by a supplemental indenture dated April 16, 2015 (collectively, the “Indenture”), among we, the Guarantors and U.S. Bank, National Association, as trustee (the “Trustee”). The Notes are our general senior unsecured obligations, and rank equally with our existing and future senior unsecured obligations and senior to all of our further subordinated indebtedness. The Notes accrue interest at a rate of 5.625% per year, payable semi-annually in cash in arrears on April 15 and October 15 of each year, commencing October 15, 2015. Interest accrues from the issue date of the Notes.

At any time on or after April 15, 2018, we may redeem some or all of the Notes at the redemption prices specified in the Indenture, plus accrued and unpaid interest to the date of redemption. Prior to April 15, 2018, we may redeem up to 40% of the aggregate principal amount of the Notes with the net cash proceeds from certain equity offerings at a redemption price equal to 105.625% of the aggregate principal amount of the Notes, plus accrued and unpaid interest, if any, provided that at least 60% of the original aggregate principal amount of the Notes remains outstanding after redemption. In addition, we may redeem some or all of the Notes at any time prior to April 15, 2018 at a redemption price equal to 100% of the principal amount of the Notes plus a make whole premium described in the Indenture, plus accrued and unpaid interest.

The Indenture includes covenants which, subject to certain exceptions, limit the ability of we and our restricted subsidiaries (as defined in the Indenture) to, among other things, incur additional indebtedness, make certain types of restricted payments, incur liens on assets of us or the restricted subsidiaries, engage in asset sales and enter into transactions with affiliates. Upon a change of control (as defined in the Indenture), we may be required to make an offer to repurchase the Notes at 101% of their principal amount, plus accrued and unpaid interest. The Indenture also contains customary events of default.

Cash Flow Summary

Cash and cash equivalents were $127.3 million at September 30, 2015 as compared with $9.1 million at September 30, 2014.

Our cash flows from operating, investing and financing activities, as reported in our Consolidated Financial Statements included elsewhere in this report, are summarized as follows (in thousands):

	For the nine months ended September 30,
	2014			2015
Net cash provided by operating activities	$	24,961		$	41,628
Net cash used in investing activities		(197,261	)		(16,593	)
Net cash provided by financing activities		168,932			94,000
Exchange rate impact on cash and cash equivalents		(350	)		(1,448	)
Net increase (decrease) in cash and cash equivalents	$	(3,718	)	$	117,587

Operating Activities. Net cash provided by operating activities was $41.6 million for the nine months ended September 30, 2015 compared with net cash provided by operating activities of $25.0 million for the nine months ended September 30, 2014. Net cash provided by operating activities for 2015 consisted of our net income of $1.3 million and net non-cash charges of $74.7 million (principally including $41.6 million in depreciation and amortization, $18.6 million in loss on early extinguishment of debt and $18.1 million in share-based compensation, offset by the change in deferred income taxes of $7.8 million) offset by a net increase in working capital of approximately $34.4 million. The increase in working capital primarily consisted of increases in accounts receivable offset by an increase in accounts payable and accrued expenses.

Net cash provided by operating activities for 2014 consisted of our net income of $6.7 million and net non-cash charges of $43.5 million (principally including $44.9 million in depreciation and amortization and $14.7 million in share-based compensation, offset by the excess tax benefit related to share-based compensation of $12.7 million and deferred income taxes of $9.8 million) offset by a net increase in working capital of approximately $25.2 million. The 2014 increase in working capital primarily consisted of increases in accounts receivable in our U.K. business and increased prepaid expenses and other current assets offset by increased accounts payable and accrued expenses.

Investing Activities. Net cash used in investing activities was $16.6 million for the nine months ended September 30, 2015 as compared to net cash used in investing activities of $197.3 million for the nine months ended September 30, 2014. The 2015 decreased use of cash was primarily attributable to decreased payments associated with acquisitions of $175.6 million as compared to the comparable prior year period and by $4.5 million in increased proceeds related to our foreign currency net investment hedges as compared to the comparable prior year period.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Financing Activities. Net cash provided by financing activities was $94.0 million for the nine months ended September 30, 2015 as compared to net cash provided by financing activities of $168.9 million for the nine months ended September 30, 2014. The 2015 cash provided was primarily attributable to the net redemption and borrowings of senior notes of $235.4 million and proceeds from the exercise of options and warrants of $13.7 million, offset by net repayments under our Senior Secured Revolving Credit Facility of $143.9 million and the payment of deferred financing costs of $8.7 million.

Net cash provided by financing activities for 2014 was primarily attributable to net borrowings under our Senior Secured Revolving Credit Facility of $118.3 million, the proceeds from the exercise of options and warrants of $35.4 million and excess tax benefit related to share-based compensation of $12.7 million.

Contingencies

We record contingent liabilities resulting from asserted and unasserted claims against us when it is probable that a liability has been incurred and the amount of the loss is reasonably estimable. We disclose contingent liabilities when there is a reasonable possibility that the ultimate loss will exceed the recorded liability. Estimating probable losses requires analysis of multiple factors, in some cases including judgments about the potential actions of third-party claimants and courts. Therefore, actual losses in any future period are inherently uncertain. We currently are not involved in any material legal proceedings. It is possible, however, that future results of operations for any particular quarterly or annual period could be materially affected by changes in our assumptions or the effectiveness of our strategies related to any future proceedings. Contingent liabilities are described in Note 9 to the consolidated financial statements included elsewhere in this report.

Contractual Obligations and Commitments

Our contractual cash payment obligations as of September 30, 2015 are set forth below (in thousands):

					Payments due by year ending December 31,
	Total		Period from October 1, 2015 to December 31, 2015		2016		2017		2018		2019		Thereafter
Amounts outstanding under senior unsecured notes payable	$	500,000	$	—	$	—	$	—	$	—	$	—	$	500,000

Operating leases		51,715		3,529		13,235		11,814		9,562		6,588		6,987

Amounts outstanding under working capital facilities		38,838		—		—		—		38,838		—		—

Totals	$	590,553	$	3,529	$	13,235	$	11,814	$	48,400	$	6,588	$	506,987

As of September 30, 2015, we leased our office spaces for our corporate locations in Atlanta, Georgia and New York, New York and also for our 66 service centers in various cities under non-cancelable lease agreements. We own an office facility in Sarasota, Florida.

We have certain contractual obligations including various debt agreements with requirements to make interest payments. Amounts outstanding under the Notes are subject to a fixed interest rate of 5.625% and interest is expected to be $28.1 million annually with semi-annual payments that begin in October 2015 and end in April 2023. Additionally, certain amounts are subject to the level of borrowings in future periods and the interest rate for the applicable periods, and therefore the amounts of these payments are not determinable. Based upon amounts outstanding at September 30, 2015 and applicable interest rates currently of 2.9%, interest amounts are expected to be approximately $282,000 for the three months ended December 31, 2015, approximately $1.1 million for the years ended December 31, 2016 and December 31, 2017 and approximately $329,000 for the year ended December 31, 2018.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Off-Balance Sheet Arrangements

We engage in no activities, obligations or exposures associated with off-balance sheet arrangements.

Critical Accounting Policies and Estimates

Overview and Definitions

We have identified the policies below as critical to our business operations and understanding of our results of operations. The impact and any associated risks related to these policies on our business operations are discussed throughout this management’s discussion and analysis of financial condition and results of operations where such policies affect our reported and expected financial results. Our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, require us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, cash flow and related disclosure of contingent assets and liabilities. Our estimates include those related to accounts receivable reserves, goodwill and other intangible assets, share-based compensation other equity instruments, income and other taxes, derivative instruments and contingent obligations. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates, and the impact of changes in key assumptions may not be linear. Our management has reviewed the application of these policies with the audit committee of our Board of Directors. For a detailed discussion on the application of these and other accounting policies, see Note 2 to the consolidated financial statements included elsewhere in this report. We believe that our most critical accounting policies and estimates relate to the following:

Revenue Recognition

Revenue related to IMEs, peer reviews, bill reviews, administrative support services and Medicare compliance services is recognized at the time services have been performed and the report is shipped to the end user. We believe that recognizing revenue at the time the report is shipped is appropriate because we meet the following four criteria in accordance with ASC 605-10-S25, Revenue Recognition: Overall, (i) persuasive evidence that arrangement exists, (ii) shipment has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. We report revenues net of any sales, use and value added taxes.

Revenue related to other IME services, including litigation support services, medical record retrieval services and case management services where no report is generated, is recognized at the time the service is performed. We believe that recognizing revenue at the time the service is performed is appropriate because we meet the following four criteria in accordance with ASC 605-10-S25, (i) persuasive evidence that arrangement exists, (ii) services have been rendered, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured.

Certain agreements with customers in the U.K. include provisions whereby collection of the amounts billed are contingent on the favorable outcome of the claim. We have deemed these provisions to preclude revenue recognition at the time of performance, as collectability is not reasonably assured and the cash payments are contingent, and are deferring these revenues, net of estimated costs, until the case has been settled the cash has been collected and the contingency has been resolved.

Should changes in conditions cause management to determine these criteria are not met for certain future transactions, revenue recognized for any reporting period could be adversely affected.

Trade Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable balances consist of amounts owed to us for services provided in the normal course of business and are reported net of an allowance for doubtful accounts. Generally, no collateral is received from clients and the collectability of trade receivable balances is regularly evaluated based on a combination of factors such as client credit-worthiness, past transaction history with the customer, current economic industry trends and changes in customer payment patterns and additions to the allowance are made based on these trends. Accounts are reviewed regularly for collectability and those deemed uncollectible are written off.

We assume, that on average, all accounts receivable will be collected within one year and thus classify these as current assets; however, there are certain receivables, primarily in the U.K., that have aged longer than one year as of December 31, 2014 and September 30, 2015, and we have recorded an estimate for those receivables that will not be collected within one year as long-term in the Consolidated Balance Sheets contained elsewhere in this report.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Goodwill and Other Intangible Assets

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Based on the provisions of ASC 350, Intangibles—Goodwill and Other (“ASC 350”), goodwill and indefinite lived intangible assets are tested for impairment annually or more frequently if impairment indicators arise. We evaluate the carrying value of goodwill during the fourth quarter of each fiscal year and between annual valuations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting units below their carrying amount. Such circumstances include: (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. When evaluating whether goodwill is impaired, we compare the fair value of the reporting units to which the goodwill is assigned to the reporting unit’s carrying amount, including goodwill. The fair value of the reporting units is estimated using primarily the income, or discounted cash flows, approach. If the carrying amount of a reporting unit exceeds its fair value, then the amount of the impairment loss must be measured. The impairment loss is calculated by comparing the implied fair value of the reporting unit’s goodwill to its carrying amount. In calculating the implied fair value of the reporting unit’s goodwill, the fair value of the reporting unit is allocated in a hypothetical analysis to all of the other assets and liabilities, including any unrecognized intangible assets, of that unit based on their fair values. The excess of the fair value of a reporting unit over the amount assigned to its other assets and liabilities is the implied fair value of goodwill. An impairment loss would be recognized when the carrying amount of goodwill exceeds its implied fair value.

Intangible assets, including client relationships, trade names, covenants not to compete and technology that have finite lives are amortized over their useful lives.

We performed our annual impairment review of goodwill in October 2014 and reviewed subsequent events through September 30, 2015 and determined that the fair value of our reporting units substantially exceed their carrying value, and goodwill was not impaired as of year end. Further, we believe that there have been no facts or circumstances through the date of this filing that indicate an impairment of goodwill exists.

Deferred Income Taxes

We provide for deferred income tax assets and liabilities based on the estimated future tax effects of differences between the financial and tax bases of assets and liabilities based on currently enacted tax laws. Our deferred and other tax balances are based on management’s interpretation of the tax regulations and rulings in numerous taxing jurisdictions. Income tax expense and liabilities recognized by us also reflect our best estimates and assumptions regarding, among other things, the level of future taxable income, the effect of our various tax planning strategies and uncertain tax positions. Future tax authority rulings and changes in tax laws, changes in projected levels of taxable income and future tax planning strategies could affect the actual effective tax rate and tax balances recorded by us. We follow the provisions under FASB ASC Subtopic 740-10, Income Taxes - Overall ("ASC 740") that provides a recognition threshold and measurement criteria for the financial statement recognition of a tax benefit taken or expected to be taken in a tax return. Tax benefits are recognized only when it is more likely than not, based on the technical merits, that the benefits will be sustained on examination. Tax benefits that meet the more-likely-than-not recognition threshold are measured using a probability weighting of the largest amount of tax benefit that has greater than 50% likelihood of being realized upon settlement. Whether the more-likely-than-not recognition threshold is met for a particular tax benefit is a matter of judgment based on the individual facts and circumstances evaluated in light of all available evidence as of the balance sheet date.

We are no longer subject to U.S. federal income and state tax return examinations by tax authorities before 2010 and 2009, respectively. We operate in multiple taxing jurisdictions and face audits from various tax authorities. We remain subject to examination until the statute of limitations expires for the respective tax jurisdiction. We do not anticipate that the amount of the unrecognized benefit will significantly increase or decrease within the next twelve months. We record interest and penalties related to unrecognized tax benefits in income tax expense.

Undistributed earnings of our foreign subsidiaries are considered indefinitely reinvested and, accordingly, no provision for U.S. federal income taxes has been recorded. Deferred taxes are provided for earnings outside the United States when those earnings are not considered indefinitely reinvested.

Share-Based Compensation and Other Equity Instruments

Our stock incentive plan provides for the granting of stock options and other share-based awards including warrants, restricted stock units (“RSUs”) and shares of restricted stock, in accordance with ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires measurement of compensation cost for all share-based awards at fair value on the grant date (or measurement date, if different) and recognition of compensation expense, net of forfeitures, over the requisite service period for awards expected to vest. We use the straight-line amortization method for recognizing share-based compensation expense.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Our expected volatility assumptions are based upon the weighted average of our implied volatility, our mean reversion volatility and the median of our peer group’s most recent historical volatilities for 2014 and 2015 stock option grants. Expected life assumptions are based upon the “simplified” method for those options issued since our IPO which were determined to be issued approximately at-the-money. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued.

The fair value of shares of restricted stock and RSUs is determined based upon the market price of the underlying common stock as of the date of grant. Additional information regarding our valuation of common stock and equity awards is set forth in Note 2 to our consolidated financial statements included elsewhere in this report.

Accounting for Acquisitions

Accounting for acquisitions requires us to recognize and measure identifiable assets acquired, liabilities assumed and any non-controlling interest in the acquired entity. Our accounting for acquisitions involves significant judgments and estimates, including the fair value of certain forms of consideration such as our common stock, the fair value of acquired intangible assets, which involve projections of future revenues, cash flows and terminal value, which are then discounted at an estimated discount rate, the fair value of other acquired assets and assumed liabilities, including potential contingencies, and the useful lives of the assets. The projections are developed using internal forecasts, available industry and market data and estimates of long-term rates of growth for our business. The impact of prior or future acquisitions on our financial position or results of operations may be materially impacted by the change in or initial selection of assumptions and estimates.

Financial Instruments

Our financial assets and (liabilities), which are measured at fair value on a recurring basis, are categorized using the fair value hierarchy at December 31, 2014 and September 30, 2015, and are as follows (in thousands):

	Level 1		Level 2		Level 3			Total
As of December 31, 2014
Financial instruments:
Contingent consideration	$	—	$	—	$	(6,587	)	$	(6,587	)
Foreign currency derivative asset		—		272		—			272


As of September 30, 2015
Financial instruments:
Foreign currency derivative asset	$	—	$	2,351	$	—		$	2,351

The contingent consideration relates to earnout provisions recorded in conjunction with certain acquisitions completed in 2013 and 2014 (see Note 3 of the accompanying Consolidated Financial Statements). Of the total decrease in fair value of the contingent consideration of $6.6 million in 2015, $5.1 million was settled as cash consideration to satisfy installments related to a 2013 and 2014 acquisition and the Company recorded $1.5 million in adjustments to the fair value of the obligation related to milestones which were not achieved, or expected to be achieved, recorded to SGA expenses, offset by $162,000 recorded in interest and other expenses, net in the Consolidated Statements of Comprehensive Income (Loss) due to changes in the fair value of the contingent consideration and the remaining change is due to currency fluctuations.

The fair value of the foreign currency derivative was determined using observable market inputs such as foreign currency exchange rates and considers our nonperformance risk and that of our counterparties.

Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In April 2014, the FASB issued ASU No. 2014-08, (Topic 205 and 360), “Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity” (“ASU 2014-08”) which amends the definition for what types of asset disposals are to be considered discontinued operations, and amends the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 also enhances the convergence of the FASB’s and the International Accounting Standard Board’s reporting requirements for discontinued operations. The amendments in this update are effective for fiscal periods beginning on or after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. We adopted the provisions of this standard effective January 1, 2015 and the adoption of these provisions did not have a material impact on our financial position, results of operations and cash flows.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Accounting Pronouncements Not Yet Adopted

In May 2014, the FASB issued ASU No. 2014-09, (Topic 606): Revenue from Contracts with Customers (“ASU 2014-09”) which supersedes the revenue recognition requirements in “Topic 605, Revenue Recognition” and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective retrospectively for annual or interim reporting periods beginning after December 15, 2017, with early application not permitted. We are currently evaluating the impact of this standard on our financial position, results of operations and cash flows.

In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-05”) which defines management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. Currently, financial statements are prepared under the presumption that the reporting organization will continue to operate as a going concern, except in limited circumstances. This going concern basis of accounting is critical to financial reporting because it establishes the fundamental basis for measuring and classifying assets and liabilities. ASU 2014-15 provides guidance regarding management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern and the related footnote disclosures. The amendments are effective for the year ending December 31, 2016, and for interim periods beginning the first quarter of 2017, with early application permitted. We plan to adopt the provisions for the year ending December 31, 2016 and will provide such disclosures as required if there are conditions and events that raise substantial doubt about its ability to continue as a going concern. We currently do not expect the adoption to have a material impact on our consolidated financial statements.

In April 2015, the FASB issued ASU No. 2015-03, “Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”) which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in ASU 2015-03. The amendments in this update are effective for fiscal periods beginning on or after December 15, 2015, and interim periods within those fiscal years. We are currently evaluating the impact of this standard on our financial position, results of operations and cash flows.

In September 2015, the FASB issued ASU No. 2015-16, “Business Combinations (Topic 805) Simplifying the Accounting for Measurement-Period Adjustments” which requires that an acquirer recognize adjustments to estimated amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments also require an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the estimated amounts had been recognized as of the acquisition date. The amendments in this update are effective for fiscal periods beginning on or after December 15, 2015, and interim periods within those fiscal years. We plan to adopt the provisions for the year ending December 31, 2016 and currently do not expect the adoption to have a material impact on our consolidated financial statements.

There were various other accounting standards and interpretations issued during 2014 and 2015 we have not yet been required to adopt, none of which are expected to have a material impact on our financial position, results of operations and cash flows.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure results primarily from fluctuations in interest rates, foreign exchange rates as well as inflation. In the normal course of business, we are exposed to market risks, including changes in interest rates and foreign exchange rates which affect our debt as well as cash flows. We may also face additional exchange rate risk in the future as we expand our business internationally.

Interest Rate Risk. As of September 30, 2015, we had cash and cash equivalents totaling approximately $127.3 million. These amounts were held for future acquisition and working capital purposes and were held in non-interest bearing accounts, of which $115.2 million were held in deposit accounts in the U.S. with only standard FDIC insurance coverage for deposit accounts up to $250,000, per depositor and account ownership category.

Our outstanding debts of $38.8 million at September 30, 2015 related to indebtedness under our working capital facilities contain floating interest rates. Thus, our interest rate is subject to market risk in the form of fluctuations in interest rates. The effect of a hypothetical one percentage point increase in our variable rate debt would result in an increase of approximately $388,000 in our annual pre-tax net income assuming no further changes in the amount of borrowings subject to variable rate interest from amounts outstanding at September 30, 2015.

Foreign Exchange Risk. As of September 30, 2015, we have foreign currency risks related to our revenues and operating expenses denominated in currencies other than the U.S. dollar, namely, the Canadian dollar, the Pound Sterling and the Australian dollar. Our financial results could be affected by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. We do not currently hedge our exposure to foreign currency exchange rate fluctuations related to the Canadian dollar given that the net difference between foreign currency denominated revenue and expenses is immaterial. In the future, however, we may hedge such exposure to foreign currency exchange rate fluctuations in this currency.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Beginning in the second quarter of 2013, in order to protect against foreign currency exposure in our Australian operations, we entered into forward foreign currency contracts as a hedge of AUD $60.0 million of its net investment in Australia. Beginning in the third quarter of 2013, we also entered into forward foreign currency contracts as a hedge of £40.0 million of our net investment in the U.K. We settled certain of our hedge positions during the 2014 year and the first three quarters of 2015 and (made payments) or were paid $(362,000) and $4.1 million, respectively, in net settlements. This amount was classified in accumulated other comprehensive loss in our Consolidated Balance Sheet (see Note 2 to the Consolidated Financial Statements included elsewhere in this report), offsetting the currency translation adjustment of the related net investment that is also recorded in accumulated other comprehensive loss, and is reported net of the effect of income taxes.

As of December 31, 2014, we had a net asset of $272,000 recorded in other current assets, with the offsetting net unrealized gain being recorded in accumulated other comprehensive loss in our Consolidated Balance Sheets associated with open forward foreign currency contracts which matured in January of 2015. As of September 30, 2015, we had a net asset of $2.4 million recorded in other current assets, with the offsetting net unrealized gain being recorded in accumulated other comprehensive income in our Consolidated Balance Sheets associated with open forward foreign currency contracts which matured in October of 2015.

Item 4. Controls and Procedures

As required by Rule 13a-15 under the Securities Exchange Act of 1934, an evaluation was carried out under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2015. Based upon our evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2015, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting during the period ended September 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

The Company is currently a party to various legal proceedings arising from the normal course of business activities. While the Company does not presently believe that the ultimate outcome of such proceedings will have a material impact on its business, operating results or financial condition, litigation is subject to inherent uncertainties. If an unfavorable ruling were to occur, it is possible that such ruling could have a material adverse impact on our business, operating results or financial condition in the period in which the ruling occurs. Our current estimates of the potential impact from such legal proceedings could change in the future.

Item 1A. Risk Factors

There have been no material changes in the risks facing the Company as described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Dividend Policy

Since the Company’s incorporation in 2007, the Company has not declared or paid any dividends on its common stock. The Company currently intends to retain all of the Company’s future earnings, if any, to finance the growth and development of the Company’s business and does not anticipate paying cash dividends for the foreseeable future. The Senior Secured Revolving Credit Facility and the Indenture restrict the Company’s ability to pay cash dividends, and any future financing agreements may restrict the Company from paying any type of dividends.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit Number		Title

2.1		Agreement and Plan of Merger, dated September 23, 2010, by and among ExamWorks Group, Inc., ExamWorks, Inc. and ExamWorks Merger Sub, Inc. (filed as Exhibit 2.1 to ExamWorks’ Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 13, 2010 and incorporated by reference herein).

2.2		Stock Purchase Agreement dated as of January 11, 2011, by and among ExamWorks Group, Inc., ExamWorks, Inc., MES Group, Inc., George C. Turek and the minority shareholders of MES Group, Inc. set forth therein (filed as Exhibit 2.1 to Form 8-K filed with the Securities and Exchange Commission on January 13, 2011 and incorporated by reference herein).

2.3*		Agreement for the sale and purchase of the entire issued share capital of Premex Group Limited dated May 10, 2011, among ExamWorks Group, Inc., ExamWorks UK Ltd. and the shareholders of Premex Group Limited set forth therein (filed as Exhibit 2.1 to Form 8-K filed with the Securities and Exchange Commission on May 13, 2011 and incorporated by reference herein).

2.4*		Tax Deed dated May 10, 2011, relating to the sale and purchase of the entire issued share capital of Premex Group between ExamWorks UK Ltd. And Covenantors set forth therein (filed as Exhibit 2.2 to Form 8-K filed with the Securities and Exchange Commission on May 13, 2011 and incorporated by reference herein).

2.5*		Sale and Purchase Deed relating to the sale and purchase of MedHealth Holdings Pty Limited dated August 31, 2012 among EW Pacific Pty Ltd, the shareholders of MedHealth Holdings Pty Limited set forth therein, and certain additional restrained parties set forth therein (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on August 31, 2012).

2.6*		Additional Sellers Deed relating to the sale and purchase of MedHealth Holdings Pty Limited dated August 31, 2012 among EW Pacific Pty Ltd and certain minority shareholders of MedHealth Holdings Pty Limited (incorporated by reference to Exhibit 2.2 to the Company’s Form 8-K filed with the Securities and Exchange Commission on August 31, 2012).

2.7*		Stock Purchase Agreement dated as of February 3, 2014, by and among Exam Works, Inc., G&L Intermediate Holdings, Inc., G&L Investment Holdings, Inc., ABRY Partners V, L.P. and ABRY Senior Equity II, L.P (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on February 4, 2014).

2.8*		Stock Purchase Agreement dated as of June 6, 2014, by and among ExamWorks, Inc. and the shareholders of Ability Services Network, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on June 9, 2014).

3.1.1		Amended and Restated Certificate of Incorporation of ExamWorks (incorporated by reference to Exhibit 3.1 to Form 10-K filed with the Securities and Exchange Commission on March 11, 2011).

3.1.2		Second Amended and Restated Bylaws of ExamWorks (incorporated by reference to Exhibit 3.1 to Form 8-K filed with the Securities and Exchange Commission on October 30, 2013).

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

4.1		Form of Common Stock Certificate of ExamWorks (filed as Exhibit 4.1 to Amendment No. 3 to ExamWorks’ Registration Statement on Form S-1 filed with the Securities and Exchange Commission on October 21, 2010 and incorporated by reference herein).

4.2		Indenture dated July 19, 2011, by and among ExamWorks Group, Inc., the Guarantors party thereto, and U.S. Bank, National Association, as Trustee (including Form of 9% Note Due 2019) (filed as Exhibit 4.1 to Form 8-K filed with the Securities and Exchange Commission on July 22, 2011 and incorporated by reference herein).

4.3		Registration Rights Agreement dated July 19, 2011 by and among ExamWorks Group, Inc., the Guarantors party thereto, and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representative of the several Initial Purchasers (filed as Exhibit 4.2 to Form 8-K filed with the Securities and Exchange Commission on July 22, 2011 and incorporated by reference herein).

4.4		Form of 9% Senior Unsecured Exchange Note Due 2019 and Form of Exchange Guarantee (filed as Exhibit 4.4 to Form S-4 filed with the Securities and Exchange Commission on April 4, 2012 and incorporated by reference herein).

4.5		Indenture, dated April 16, 2015, among ExamWorks Group, Inc., the Guarantors party thereto, and U.S. Bank National Association, as Trustee (filed as Exhibit 4.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 17, 2015 and incorporated by reference herein).

4.6		Supplemental Indenture, dated April 16, 2015, among ExamWorks Group, Inc., the Guarantors party thereto, and U.S. Bank National Association, as Trustee (including the Form of 5.625% Note Due 2023) (filed as Exhibit 4.2 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 17, 2015 and incorporated by reference herein).

4.7		Form of 5.625% Senior Unsecured Note Due 2023 and Form of Guarantee (filed as Exhibit 4.3 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 17, 2015 and incorporated by reference herein).

10.1		Amended and Restated Credit Agreement, dated April 16, 2015, among the Company, the Guarantors party thereto, Bank of America, N.A., as administrative agent, and the other lenders party thereto (filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 17, 2015 and incorporated by reference herein).

10.2		First Amendment to Amended and Restated Credit Agreement, dated as of June 1, 2015, by and among ExamWorks Group, Inc., as Borrower, Bank of America, N.A., as Administrative Agent, and the Guarantors and Lenders party thereto, amending the Amended and Restated Credit Agreement dated April 16, 2015 (filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on June 2, 2015 and incorporated by reference herein).

10.3		Amendment Letter, dated April 16, 2015, by and between UK Independent Medical Services Ltd and Barclays Bank PLC, amending the Sales Finance Agreement, dated September 30, 2010 (filed as Exhibit 10.2 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 17, 2015 and incorporated by reference herein).

10.4		Amendment Letter, dated April 16, 2015, by and between Barclays Bank PLC and Premex Services Limited, amending the Sales Finance Agreement, dated May 12, 2011 (filed as Exhibit 10.3 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 17, 2015 and incorporated by reference herein).

10.5		Second Amendment to ExamWorks Group, Inc. Amended and Restated 2008 Stock Incentive Plan, as amended, dated May 12, 2015 (filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on May 14, 2015 and incorporated by reference herein).

31.1		Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a)

31.2		Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a)

32.1		Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

* Schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementary copies of any omitted schedules to the Securities and Exchange Commission upon request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	EXAMWORKS GROUP, INC.



Date: November 5, 2015	By:	/s/ J. Miguel Fernandez de Castro
		J. Miguel Fernandez de Castro
		Senior Executive Vice President and Chief

ExamWorks Group, Inc. - FORM 10-Q - November 5, 2015

Attached files

ExamWorks Group, Inc. Reports